Philip Morris International (PM)

Company ID: 45 | CIK: 0001413329
10-Q view:
No 10-Q YTD data
No 10-Q 3M data
No 10-Q YTD data
No 10-Q 3M data
No 10-Q YTD data
No 10-Q 3M data
No 10-K data
No 10-Q YTD data
No 10-Q 3M data
No 10-K data
No 10-Q YTD data
No 10-Q 3M data
No 10-Q YTD data
No 10-Q 3M data
No 10-K data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q YTD data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q YTD data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q YTD data
No 10-Q 3M data
No 10-Q YTD data
No 10-Q 3M data
No 10-Q 3M data
Segments are charted by their disclosed metrics (revenue, segment profit, etc.). Each line is a single segment. Reconciliation/corporate items are excluded. Major customers are shown as a percentage of revenue. Operational KPIs are grouped by metric concept; sub-metrics appear as separate lines.

Geographic Segments

Business Unit / Product Segments

No 10-Q data

Major Customers (% of Revenue)

Operational KPIs

IQOS Consumables capacity (capacity)

Third-party cigarette operators (contractors)

No 10-Q data

Holders of record (customers)

Headcount (headcount)

Distributor inventory movements (inventory_units)

No 10-K data

Americas market share (other)

No 10-Q data

Americas regional market share (other)

No 10-Q data

Annualized dividend rate (other)

No 10-K data

Argentina market share (other)

No 10-K data

Brand market share (other)

No 10-Q data

Brand shipment volume (other)

No 10-Q data

Canada market share (other)

No 10-K data

Cigarette Market Share (other)

Cigarette market presence (other)

No 10-K data

Cigarette market share (other)

Cigarette markets (other)

Cigarette over Cigarette Market Share (other)

No 10-K data

Cigarette shipment volume (other)

No 10-K data

Cigarette shipment volume by brand (other)

No 10-K data

Cigarette shipments by brand (other)

No 10-K data

Cigarette volume growth (other)

No 10-K data

Cigarette-over-cigarette market share (other)

Cigarette-over-cigarette share (other)

No 10-Q data

Cigarettes & OTP volume growth (other)

No 10-Q data

Clinical trials initiated (other)

No 10-Q data

Combined market share (other)

No 10-K data

Contract Manufacturing Relationships (other)

No 10-Q data

Contract manufacturers (other)

No 10-Q data

Contract manufacturing markets (other)

No 10-Q data

Contract manufacturing partners (other)

No 10-Q data

Contract manufacturing relationships (other)

No 10-Q data

Countries of sale (other)

No 10-Q data

Countries served (other)

No 10-Q data

Countries with product sales (other)

Countries with sales (other)

No 10-Q data

Cumulative shares repurchased (other)

No 10-K data

Device share of RRP revenue (other)

No 10-K data

Direct farmer sourcing (other)

No 10-Q data

Direct leaf sourcing (other)

No 10-Q data

Direct material suppliers (other)

No 10-Q data

Direct materials suppliers (other)

No 10-Q data

Direct-sourced leaf share (other)

No 10-Q data

EA&A regional market share (other)

No 10-Q data

EA, AU & PMI DF market share (other)

No 10-Q data

EBITDA coverage ratio (other)

No 10-K data

EBITDA interest coverage (other)

No 10-K data

EBITDA to interest coverage (other)

No 10-K data

EBITDA to interest coverage ratio (other)

No 10-K data

EBITDA to interest ratio (other)

No 10-K data

EU market share (other)

No 10-K data

EU regional market share (other)

No 10-Q data

EU total market (other)

No 10-K data

Eastern Europe market share (other)

No 10-Q data

Effective tax rate (other)

No 10-K data

Estimated total market volume (other)

No 10-K data

Europe market share (other)

No 10-Q data

European Union market share (other)

Farmer direct sourcing (other)

No 10-Q data

France market share (other)

No 10-K data

Germany market share (other)

No 10-K data

Granted patents (other)

No 10-Q data

HTU Market Share (other)

HTU adjusted in-market sales growth (other)

No 10-K data

HTU in-market sales (other)

HTU in-market sales growth (other)

No 10-K data

HTU in-market sales volume (other)

HTU market share (other)

No 10-K data

Hand-rolled cigarette operators (other)

No 10-Q data

HeatSticks market share (other)

No 10-K data

High-share markets (other)

No 10-Q data

Holders of record (other)

No 10-Q data

IQOS availability markets (other)

No 10-Q data

IQOS device revenue share (other)

No 10-Q data

IQOS launch markets (other)

No 10-Q data

IQOS market availability (other)

No 10-K data

IQOS market presence (other)

No 10-K data

IQOS markets (other)

In-market sales growth (other)

No 10-K data

Indonesia market share (other)

No 10-K data

Industry cigarette & HTU volume (other)

No 10-Q data

Industry cigarette volume (other)

No 10-Q data

Industry volume (other)

No 10-Q data

Industry volume change (other)

No 10-K data

International Market Share (other)

No 10-Q data

International Market Share (Cigarettes + HTUs) (other)

No 10-K data

International Market Share (Cigarettes) (other)

No 10-K data

International Market Share (Ex-PRC) (other)

No 10-Q data

International Market Share (HTUs) (other)

No 10-K data

International brand mix (other)

No 10-Q data

International brands share of volume (other)

No 10-Q data

International brands volume share (other)

No 10-Q data

International cigarette market share (other)

International cigarette market share (ex-PRC) (other)

No 10-Q data

International cigarette market share ex-PRC (other)

No 10-Q data

International cigarette market share excluding China (other)

No 10-Q data

International cigarette market size (other)

No 10-Q data

International cigarette market volume (other)

No 10-Q data

International heated tobacco unit market share (other)

International industry volume (other)

No 10-Q data

International industry volume excluding China (other)

No 10-Q data

International industry volume growth (other)

No 10-K data

International market share (other)

International market share (ex-PRC) (other)

No 10-Q data

Inventory coverage (other)

No 10-K data

Italy market share (other)

No 10-K data

Japan market share (other)

No 10-K data

Korea market share (other)

No 10-K data

L&M shipments (other)

No 10-K data

ME&A regional market share (other)

No 10-Q data

Manufacturing facilities (other)

No 10-Q data

Market share (other)

Markets selling cigarettes (other)

No 10-Q data

Markets served (other)

Markets where cigarettes are sold (other)

No 10-Q data

Markets with 15%+ share (other)

No 10-Q data

Markets with BONDS/BLENDS (other)

No 10-K data

Markets with IQOS (other)

No 10-K data

Markets with IQOS available (other)

No 10-K data

Markets with Platform 1 available (other)

No 10-Q data

Markets with VEEV vaping products (other)

No 10-K data

Markets with at least 15% market share (other)

No 10-Q data

Markets with at least 15% share (other)

No 10-Q data

Markets with cigarette sales (other)

Markets with cigarettes (other)

No 10-K data

Markets with leading share (other)

No 10-Q data

Markets with modern oral pouches (other)

No 10-K data

Markets with nicotine pouch sales (other)

No 10-Q data

Markets with nicotine pouches (other)

No 10-K data

Markets with product availability (other)

No 10-K data

Markets with product sales (other)

No 10-Q data

Markets with smoke-free product sales (other)

Markets with smoke-free products (other)

Markets with ≥15% share (other)

No 10-Q data

Marlboro brand market share (other)

No 10-Q data

Marlboro cigarette market share (other)

No 10-Q data

Marlboro market share (other)

No 10-Q data

Marlboro market share (ex-PRC) (other)

No 10-Q data

Marlboro share of cigarette volume (other)

No 10-Q data

Marlboro share of shipment volume (other)

No 10-Q data

Marlboro shipments (other)

No 10-K data

Marlboro volume share (other)

No 10-Q data

Mexico market share (other)

No 10-K data

Modern oral markets (other)

No 10-Q data

Nicotine pouch markets (other)

Non-tobacco suppliers (other)

No 10-Q data

North Africa market share (other)

No 10-K data

Number of Reportable Segments (other)

OTP market share (other)

No 10-K data

OTP shipment volume growth (other)

OTP volume growth (other)

Oral product shipment volume (other)

No 10-K data

Other tobacco products volume growth (other)

No 10-K data

PMI EU market share (other)

No 10-K data

PMI Japan market share (other)

No 10-K data

PMI Mexico market share (other)

No 10-K data

PMI cigarette market share (other)

PMI market share (other)

No 10-K data

Patent Applications Pending (other)

No 10-Q data

Patents Granted (other)

No 10-Q data

Pending litigation cases (other)

No 10-K data

Pending patent applications (other)

No 10-Q data

Philippines market share (other)

No 10-K data

Platform 1 availability (other)

No 10-Q data

Platform 1 markets (other)

No 10-Q data

Poland market share (other)

No 10-K data

Positions eliminated (other)

Quarterly dividend per share (other)

No 10-K data

R&D allocated to RRPs (other)

No 10-Q data

RRP platforms in development (other)

No 10-K data

Regional market share (other)

No 10-Q data

Research and development expense (other)

No 10-Q data

Russia market share (other)

No 10-K data

S&SA regional market share (other)

No 10-Q data

SSEA, CIS & MEA market share (other)

No 10-Q data

Share repurchases (other)

No 10-K data

Shares available under 2017 Plan (other)

No 10-K data

Shares outstanding (other)

No 10-K data

Shares repurchased (other)

Smoke-free markets (other)

Smoke-free markets available (other)

No 10-K data

Smoke-free product markets (other)

No 10-Q data

Smoke-free shipment volume (other)

No 10-K data

Spain market share (other)

No 10-K data

Third-party cigarette operators (other)

No 10-Q data

Third-party contract manufacturers (other)

No 10-Q data

Third-party kretek operators (other)

No 10-Q data

Third-party operators (other)

No 10-Q data

Top brands volume share (other)

No 10-Q data

Top ten supplier share (other)

No 10-Q data

Top-10 supplier share (other)

No 10-Q data

Top-5 brands share of cigarette volume (other)

No 10-Q data

Total EU market share (other)

No 10-K data

Total International Market Share (other)

Total cigarette market (other)

No 10-K data

Total international market share (other)

Total international market size (other)

No 10-Q data

Total international market volume (other)

No 10-Q data

Total market share (other)

No 10-K data

Total market size (other)

No 10-K data

Total market volume (other)

Total shipment volume growth (other)

No 10-K data

Total volume growth (other)

No 10-K data

Trade receivables sold outstanding (other)

No 10-K data

Turkey market share (other)

No 10-K data

U.S. oral smoke-free shipments (other)

No 10-K data

Ukraine market share (other)

No 10-K data

VEEV markets (other)

No 10-K data

Worldwide market share (other)

No 10-Q data

ZYN retail outlets (other)

No 10-K data

ZYN shipments (other)

No 10-K data

iQOS markets (other)

No 10-K data

International industry volume excluding China (production_volume)

Heated Tobacco Unit Factories (properties)

No 10-Q data

Retail distribution points (stores)

No 10-K data

Smoke-Free Product Shipment Volume (units_shipped)

IQOS converted users (users)

Human capital disclosures. Workforce totals and demographics are point-in-time. Flow metrics use the year-to-date period for 10-Q and full year for 10-K. Workforce actions (RIFs, restructurings, acquisition-related changes) are listed in the table at the bottom.

Workforce Totals

No 10-Q data

Demographics

No 10-Q data

Workforce Breakdowns

No 10-Q data

HCM Metrics — Point-in-Time

No point-in-time HCM metrics found.

HCM Metrics — Flow (Annual / YTD)

No flow HCM metrics found.

Workforce Actions

Period EndTypeStatusAffected% WorkforceAnnouncedExpected CompletionGeographySegment / FunctionChargeSourceNote
2026-06-30restructuringin_progress2026-01-01United StatesU.S. organizationUSD 30 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Footprint optimization initiatives announced in Q1 2026 under the Further Integration Program; six-month 2026 pre-tax charges of $30 million comprised of $25 million employee separation and related costs and $5 million asset impairments. Full-year 2026 charges expected at approximately $50 million. No employee count disclosed.
2026-06-30plant_closureannounced2026-01-01Richmond, Virginia, United StatesU.S. organizationrestructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Planned closure of the Richmond office with transition of certain roles and capabilities to the Tampa Business Solutions Center and the Stamford, Connecticut U.S. headquarters. No employee count disclosed.
2026-06-30plant_closureannounced2026-01-01Dothan, Alabama, United StatesU.S. cigar manufacturingrestructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Closure of the Dothan, Alabama cigar manufacturing facility with consolidation of cigar production into PMI's manufacturing footprint in the Dominican Republic. No employee count disclosed.
2026-06-30restructuringin_progress2026-03-312026-12-31United StatesU.S. segment (Further Integration Program)USD 30 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Footprint optimization announced in Q1 2026: closure of Richmond office, transition of roles to Tampa Business Solutions Center and Stamford HQ, closure of Dothan, Alabama cigar facility with production consolidated to the Dominican Republic. Pre-tax charges of $30M recorded in H1 2026 ($6M in Q2); full-year 2026 charges expected to be approximately $50M. No employee count disclosed.
2026-06-30restructuringin_progress2026-03-312026-12-31United StatesCorporate / U.S. OperationsUSD 30 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Further Integration Program (FIP) announced in Q1 2026. Includes closure of Richmond office, transition of roles to Tampa and Stamford, and closure of Dothan cigar facility. Charges include $25M employee separation and $5M asset impairment. Full year expected charge is $50M. Employee count not disclosed.
2026-06-30restructuringin_progressUSD 25,000,000 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2026-03-31restructuringin_progress2026-01-01United StatesU.S. segmentUSD 24 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Further Integration Program footprint optimization: closure of Richmond office, transition of roles to Tampa Business Solutions Center and Stamford HQ, closure of Dothan, Alabama cigar manufacturing facility with production consolidated into Dominican Republic. Q1 2026 pre-tax charges of $24 million ($19 million employee separation and related costs, $5 million asset impairments); full-year 2026 charges expected at approximately $55 million. No employee headcount affected was disclosed.
2026-03-31restructuringin_progress2026-03-31United StatesU.S. organization — Further Integration Program (FIP)USD 24 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Q1 2026 pre-tax charges: $19M employee separation/related costs and $5M asset impairment. Includes planned closure of Richmond office, transition of roles to Tampa Business Solutions Center and Stamford HQ, closure of Dothan, Alabama cigar facility with production consolidated to the Dominican Republic. Full-year 2026 charges expected to be approximately $55M. No employee count disclosed.
2026-03-31restructuringin_progress2026-01-012027-12-31United StatesU.S. SegmentUSD 24 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Further Integration Program (FIP) including closure of Richmond office and Dothan cigar facility. Charges include $19M employee separation costs and $5M asset impairment. Employee count not disclosed.
2026-03-31restructuringin_progressUSD 19,000,000 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2025-12-31plant_closurecompleted2024-10-292025-06-30GermanyManufacturing — combustible tobacco production (Berlin and Dresden factories)USD 241 (millions)restructuring_footnote
f5-10k / GLM-5.3-flash-HTML
Consultations with employee representatives began October 2024 and concluded April 2025; production ended by end of Q2 2025. Charge comprises $125M pension and employee separation costs, $24M contract termination and other costs, and $92M non-cash asset impairment. Affected headcount not disclosed. Restructuring liability of $115M at year-end 2025, substantially payable by end of 2026.
2025-12-31plant_closurecompleted2024-10-292025-06-30GermanyEurope — Manufacturing (combustible tobacco)USD 241 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Closure of Berlin and Dresden cigarette factories; consultations concluded April 2025. Charge includes $125M pension/separation, $24M contract termination, $92M asset impairment. Employees affected not disclosed.
2025-12-31divestiture_reductioncompleted2025-12-31EuropeConsumer accessories and other businesses (Swedish Match legacy)USD 94 (millions)discontinued_operations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Q4 2025 sale of one business and held-for-sale classification of others; pre-tax loss of $94M. Headcount impact not disclosed.
2025-12-31restructuringcompleted2024-10-292025-06-30GermanyManufacturingUSD 241 (millions)restructuring_footnote
f5-10k / Qwen3.6-27B-Q8_0
End of combustible tobacco production in Berlin and Dresden factories. Includes pension/separation costs of $125M and asset impairment of $92M.
2025-12-31divestiture_reductioncompleted2024-09-172024-12-31EuropeWellnessUSD 199 (millions)discontinued_operations_footnote
f5-10k / Qwen3.6-27B-Q8_0
Sale of Vectura Group Ltd. resulted in pre-tax loss of $199M.
2025-12-31divestiture_reductioncompleted2025-10-012025-12-31EuropeConsumer AccessoriesUSD 94 (millions)discontinued_operations_footnote
f5-10k / Qwen3.6-27B-Q8_0
Sale of one business and classification of others as held-for-sale (consumer accessories). Pre-tax loss of $94M.
2025-12-31restructuringin_progressUSD 149,000,000 (absolute)restructuring_footnote
f5-10k / no-ai-xblr
2025-09-30plant_closurecompleted2024-10-292025-06-30GermanyEurope segment; combustible tobacco manufacturingUSD 243 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Consultations with employee representatives began October 2024; concluded April 2025. Charges include $127M pension and employee separation costs, $24M contract termination and other cash costs, and $92M non-cash asset impairments. No employee headcount figure disclosed.
2025-09-30plant_closurecompleted2024-10-292025-06-30Germany (Berlin and Dresden)Manufacturing — Europe segmentUSD 243 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Consultations with employee representatives began 2024-10-29 and concluded April 2025; charge comprises $127M separation, $24M contract termination, $92M asset impairment. No employee headcount disclosed.
2025-09-30restructuringcompleted2024-02-01United StatesIQOS sourcing / supply chainUSD 121 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Prior-year program (Q1 2024 charges) restructured IQOS sourcing for U.S. commercialization; included $61M contract terminations and $60M asset impairments. No employee count disclosed.
2025-09-30restructuringcompleted2024-01-012024-03-31VenezuelaAmericas segment — ceased operationsUSD 47 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Prior-year program (Q1 2024) covering cessation of Venezuela operations; charge primarily non-cash ($38M CTA reclassification, $5M asset impairment). No employee count disclosed.
2025-09-30restructuringcompleted2024-10-292025-06-30GermanyManufacturingUSD 243 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Consultations concluded in April 2025 regarding end of production in Berlin and Dresden factories by end of Q2 2025. Charge includes $127M pension/employee separation and $24M contract termination costs. Employee count not disclosed.
2025-09-30restructuringin_progressUSD 151,000,000 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2025-06-30plant_closurecompleted2024-10-292025-06-30GermanyEurope; combustible tobacco manufacturingUSD 243 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Consultations began October 2024 to end production at Berlin and Dresden factories by end of Q2 2025; concluded April 2025. Charge comprises $127M pension and employee separation costs, $24M contract termination and other costs (cash), and $92M non-cash asset impairments (property lease, machinery and equipment). No employee count disclosed.
2025-06-30plant_closurecompleted2024-10-292025-06-30GermanyEurope — Manufacturing (Berlin and Dresden factories)USD 243 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Consultations with employee representatives concluded April 2025; charge includes $127M pension/separation, $24M contract termination, $92M asset impairment. No employee count disclosed.
2025-06-30restructuringin_progress2024-10-292025-06-30GermanyManufacturingUSD 243 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Consultations initiated Oct 29, 2024 to end production in Berlin and Dresden factories by end of Q2 2025. Charges include $127M pension/separation, $24M contract termination, and $92M asset impairment.
2025-06-30restructuringin_progressUSD 151,000,000 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2025-03-31plant_closurein_progress2024-10-292025-06-30GermanyManufacturing (Europe segment)USD 230 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Two German subsidiaries proposed ending production at Berlin and Dresden factories by end of Q2 2025; employee consultations concluded April 2025. Expected future pre-tax charges of at least approximately EUR 200 million (approximately $230 million), primarily in Q2 2025, covering employee severance, contract termination and asset impairment costs. No employee count disclosed.
2025-03-31plant_closureannounced2024-10-292025-06-30Germany (Berlin and Dresden)Manufacturing — Europe segmentEUR 200 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Consultations with employee representatives concluded April 2025; estimated future pre-tax charges of at least approximately EUR 200 million (approximately $230 million), primarily in Q2 2025, covering severance, contract termination and asset impairment. No employee count disclosed.
2025-03-31restructuringannounced2024-10-292025-06-30GermanyManufacturingEUR 200 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Consultations concluded in April 2025 regarding closure of Berlin and Dresden factories. Estimated pre-tax charges of at least EUR 200 million, primarily in Q2 2025, for severance, contract termination, and asset impairment. Employee count not disclosed.
2025-03-31restructuringin_progressUSD 0 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2024-12-31restructuringin_progress2024-02-01United StatesAmericas (sourcing of IQOS products for U.S. commercialization)USD 133 (millions)restructuring_footnote
f5-10k / GLM-5.3-flash-HTML
Project initiated Q1 2024 following settlement agreement with BAT affiliate and ITC order rescission. Charge comprises $73M supplier contract termination costs (including $20M prepaid commitments) and $60M non-cash asset impairments, mainly machinery and equipment. No employee headcount disclosed.
2024-12-31restructuringcompleted2024VenezuelaAmericasUSD 47 (millions)restructuring_footnote
f5-10k / GLM-5.3-flash-HTML
Operations ceased in Q1 2024. Charge comprises $38M non-cash reclassification of accumulated FX translation losses from OCI, $5M asset impairment (land and buildings), and $4M cash contract termination/severance costs. No employee headcount disclosed.
2024-12-31plant_closureannounced2024-10-292025-06-30Germany (Berlin and Dresden)Europe (manufacturing)restructuring_footnote
f5-10k / GLM-5.3-flash-HTML
Proposal by two German subsidiaries to end production at Berlin and Dresden factories by end of Q2 2025; consultations with employee representatives initiated October 29, 2024. Closure not yet probable; no related costs recorded in FY2024 and impacted-employee solutions still to be agreed. No employee headcount disclosed.
2024-12-31restructuringin_progress2024-02-01United StatesAmericas — IQOS sourcingUSD 133 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Project initiated in Q1 2024 to restructure sourcing of IQOS products for U.S. commercialization following the BAT/Nicoventures settlement. Charge includes $73M contract termination costs (including $20M prepaid commitments) and $60M asset impairment. No employee-affected count disclosed.
2024-12-31restructuringcompleted2024-01-012024-03-31VenezuelaAmericas — operations wind-downUSD 47 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
PMI ceased operations in Venezuela in Q1 2024. Charge includes $38M reclassification of cumulative FX translation losses, $5M asset impairment on land and buildings, and $4M contract termination, severance and other costs paid in cash. No employee-affected count disclosed.
2024-12-31plant_closureannounced2024-10-292025-06-30GermanyEurope — manufacturing (Berlin and Dresden factories)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Two German subsidiaries initiated consultations with employee representatives on a proposal to end production at Berlin and Dresden factories by end of Q2 2025. Closure not considered probable at year-end; no costs recorded and no employee count disclosed.
2024-12-31divestiture_reductioncompleted2024-09-172024-12-31United KingdomWellness & Healthcare — Vectura GroupUSD 199 (millions)discontinued_operations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Sale of Vectura Group to Molex Asia Holdings completed December 31, 2024 for GBP 152M upfront plus contingent payments. Pre-tax loss of $199M ($206M including tax costs). No headcount transferred or removed disclosed.
2024-12-31acquisition_additioncompleted2024-05-162024-05-16EgyptSSEA, CIS & MEA — United Tobacco Company (UTC)business_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
PMI acquired controlling interest of 54.25% in UTC (Egypt) on May 16, 2024, increasing its economic interest from approximately 25%. Total purchase price for incremental interest of $316M. No employee headcount added disclosed.
2024-12-31restructuringcompleted2024-01-012024-12-31United StatesSmoke-Free Inhalable ProductsUSD 133 (millions)restructuring_footnote
f5-10k / Qwen3.6-27B-Q8_0
Restructuring of sourcing of IQOS products to be commercialized in the U.S. Includes contract termination costs of $73 million and asset impairment costs of $60 million.
2024-12-31plant_closurecompleted2024-01-012024-03-31VenezuelaAmericasUSD 47 (millions)restructuring_footnote
f5-10k / Qwen3.6-27B-Q8_0
Cessation of operations in Venezuela. Includes reclassification of accumulated foreign currency translation losses ($38 million), asset impairment ($5 million), and contract termination/severance ($4 million).
2024-12-31restructuringannounced2024-10-292025-06-30GermanyManufacturingrestructuring_footnote
f5-10k / Qwen3.6-27B-Q8_0
Proposal to end production in Berlin and Dresden factories. Closure not considered probable; no costs recorded in Q4 2024.
2024-12-31restructuringin_progressUSD 77,000,000 (absolute)restructuring_footnote
f5-10k / no-ai-xblr
2024-09-30restructuringin_progress2024-02-01United StatesPlatform 1 (IQOS) products sourcing for the U.S. marketUSD 121 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Q1 2024 pre-tax charge to restructure sourcing of IQOS products for U.S. commercialization; includes $61M contract termination costs (with $20M prepaid commitments) and $60M non-cash asset impairments. No employee count disclosed.
2024-09-30plant_closurecompleted2024-01-01VenezuelaAmericasUSD 47 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
PMI ceased operations in Venezuela in Q1 2024; charge includes $38M reclassification of accumulated currency translation losses, $5M asset impairment, and $4M contract termination, severance and other cash costs. No employee count disclosed.
2024-09-30divestiture_reductionannounced2024-09-172024-12-31United KingdomWellness and Healthcare (Vectura Group Ltd.)USD 198 (millions)business_combinations_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Definitive agreement to sell Vectura Group Ltd. to Molex Asia Holdings Ltd. for GBP 150 million plus deferred payments up to GBP 148 million; $198M impairment on held-for-sale classification. No employee count disclosed.
2024-09-30divestiture_reductionannounced2024-09-172024-12-31United KingdomWellness and HealthcareUSD 198 (millions)other
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Sale of Vectura Group Ltd. to Molex Asia Holdings Ltd.; impairment charge relates to held-for-sale classification, not severance. No employee count disclosed.
2024-09-30acquisition_additioncompleted2024-05-162024-05-16EgyptSSEA, CIS & MEAbusiness_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
PMI acquired controlling interest (54.25%) in United Tobacco Company; no headcount added disclosed.
2024-09-30plant_closurecompleted2024-01-012024-03-31VenezuelaAmericasUSD 47 (millions)other
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Cessation of Venezuela operations in Q1 2024; charge includes severance and contract termination costs but no employee count disclosed.
2024-09-30restructuringcompleted2024-01-012024-03-31United StatesManufacturingUSD 121 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Restructuring of sourcing for Platform 1 (IQOS) products for the U.S. market. Includes contract termination costs of $61 million and asset impairment of $60 million. Employee count not disclosed.
2024-09-30restructuringcompleted2024-01-012024-03-31VenezuelaAmericasUSD 47 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Cessation of operations in Venezuela. Includes contract termination, severance, and other related costs of $4 million paid in cash, plus non-cash charges. Employee count not disclosed.
2024-09-30restructuringin_progressUSD 65,000,000 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2024-06-30restructuringin_progress2024-02-01United StatesPlatform 1 (IQOS) products sourcing for the U.S. marketUSD 121 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Q1 2024 pre-tax charge to restructure sourcing of IQOS products for U.S. commercialization; includes $61M supplier contract termination costs (with $20M prepaid commitments) and $60M non-cash asset impairments, mainly machinery and equipment. No employee count disclosed.
2024-06-30plant_closurecompleted2024-01-01VenezuelaAmericasUSD 47 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
PMI ceased operations in Venezuela in Q1 2024; charge includes $38M reclassification of accumulated currency translation losses, $5M asset impairment on land and buildings, and $4M contract termination, severance and other cash costs. No employee count disclosed.
2024-06-30restructuringcompleted2024-01-01United StatesAmericas — Platform 1 (IQOS) sourcing for U.S. marketUSD 121 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Q1 2024 restructuring of Platform 1 sourcing for U.S. commercialization; included $61M contract termination costs and $60M asset impairment. No employee count disclosed.
2024-06-30plant_closurecompleted2024-01-01VenezuelaAmericasUSD 47 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
PMI ceased operations in Venezuela in Q1 2024; charge included $38M reclassification of FX translation losses, $5M asset impairment, and $4M contract termination/severance. No employee count disclosed.
2024-06-30acquisition_additioncompleted2024-05-162024-05-16EgyptSSEA, CIS & MEAbusiness_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
PMI acquired controlling interest of 54.25% in UTC on May 16, 2024. No headcount added disclosed.
2024-06-30restructuringin_progress2024-02-012025-12-31United StatesAmericasUSD 121 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Settlement with Nicoventures Trading Limited regarding IQOS sourcing; includes $61M contract termination and $60M asset impairment. Employee count not disclosed.
2024-06-30plant_closurecompleted2024-03-312024-03-31VenezuelaAmericasUSD 47 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Cessation of operations in Venezuela; includes $38M reclassification of currency translation losses, $5M asset impairment, and $4M contract termination/severance. Employee count not disclosed.
2024-06-30restructuringin_progressUSD 65,000,000 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2024-03-31restructuringin_progress2024-02-01United StatesPlatform 1 (IQOS) products sourcingUSD 121 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Restructuring of IQOS sourcing for U.S. commercialization following BAT settlement and ITC order rescission; includes $61M contract termination costs (incl. $20M prepaid commitments) and $60M non-cash asset impairments; no employee count disclosed.
2024-03-31plant_closurecompletedVenezuelaAmericasUSD 47 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
PMI ceased operations in Venezuela in Q1 2024; charge includes $38M reclassification of accumulated currency translation losses, $5M asset impairment (land and buildings), and $4M cash contract termination, severance and related costs; no employee count disclosed.
2024-03-31restructuringin_progress2024-02-02United StatesPlatform 1 (IQOS) sourcingUSD 121 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Restructured IQOS sourcing for U.S. commercialization after BAT settlement; includes $61M contract termination and $60M asset impairment. No employee count disclosed.
2024-03-31plant_closurecompletedVenezuelaAmericasUSD 47 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Ceased operations in Venezuela in Q1 2024; charge includes $38M CTA reclassification, $5M asset impairment, $4M contract termination/severance. No employee count disclosed.
2024-03-31restructuringin_progress2024-03-312025-12-31United StatesAmericasUSD 121 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Restructuring of sourcing for Platform 1 (IQOS) products for U.S. market. Includes $61M contract termination and $60M asset impairment. Employee count not disclosed.
2024-03-31plant_closurecompleted2024-03-312024-03-31VenezuelaAmericasUSD 47 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Cessation of operations in Venezuela. Includes $38M reclassification of currency translation losses, $5M asset impairment, and $4M contract termination/severance. Employee count not disclosed.
2024-03-31restructuringin_progressUSD 65,000,000 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2023-12-31restructuringin_progressCharges allocated across all four geographic segments (Europe, SSEA/CIS/MEA, EA/AU/PMI DF, Americas)e-vapor products manufacturing (devices and consumables)USD 109 (millions)restructuring_footnote
f5-10k / GLM-5.3-flash-HTML
Project initiated in Q1 2023 to fully outsource and restructure manufacturing of e-vapor devices and consumables. 2023 charge comprises $78M supplier contract termination costs (including $21M embedded finance lease terminations, payable in cash) and $31M non-cash asset impairments, allocated by segment (contract terminations: Europe $35M, SSEA/CIS/MEA $25M, EA/AU/PMI DF $15M, Americas $3M; asset impairments: Europe $14M, SSEA/CIS/MEA $9M, EA/AU/PMI DF $6M, Americas $2M). No employee count disclosed. Exit-cost cash payments anticipated to be substantially paid by end of 2024; exit cost liability balance was $29M at Dec 31, 2023.
2023-12-31divestiture_reductioncompleted2023-06-30SwedenLogistics (Swedish Match subsidiary SMD Logistics AB)business_combinations_footnote
f5-10k / GLM-5.3-flash-HTML
Sale of SMD Logistics AB completed June 30, 2023 (date shown is the completion date); divestiture was required by the European Commission under the EU Merger Regulation as a condition of PMI's 2022 Swedish Match acquisition. Transaction had no material impact on consolidated earnings; no employee headcount disclosed.
2023-12-31restructuringin_progress2023-03-312024-12-31GlobalE-vapor device and consumables manufacturingUSD 109 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Project to fully outsource and restructure e-vapor manufacturing initiated in Q1 2023 (exact announcement date not disclosed). Charge comprises $78M contract termination costs (including $21M embedded finance lease terminations) and $31M non-cash asset impairment; no employee count disclosed. Exit cost liability of $29M outstanding at year-end, with payments anticipated to be substantially paid by end of 2024. Charges allocated across all geographical segments.
2023-12-31otherin_progressUkraineOperations (Europe segment)other
f5-10k / MiMo-V2.6-Flash-fp8-HTML
War-driven 2023 pre-tax charges of $53M include severance payments, humanitarian salary continuation and an impairment of long-lived assets; the charge is not severance-only and no affected-employee count is disclosed. Production at the Kharkiv factory remains suspended.
2023-12-31divestiture_reductioncompleted2023-06-302023-06-30SwedenSwedish Match — SMD Logistics AB (logistics)business_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Divestiture of SMD Logistics AB was required as a condition of European Commission approval of the Swedish Match acquisition; held for sale at Dec 31, 2022 and Mar 31, 2023. No material earnings impact and no headcount disclosed.
2023-12-31restructuringcompleted2023-01-012023-12-31GlobalManufacturingUSD 109 (millions)restructuring_footnote
f5-10k / Qwen3.6-27B-Q8_0
Project to fully outsource and restructure manufacturing of e-vapor devices and consumables. Includes contract termination costs ($78M) and asset impairment ($31M). Employee count not explicitly disclosed in footnote.
2023-12-31voluntary_separationcompleted1,0202020-01-012021-12-31Switzerland, Argentina, Indonesia, Poland, United StatesOperations Center and Centralized ActivitiesUSD 308 (millions)restructuring_footnote
f5-10k / Qwen3.6-27B-Q8_0
Organizational design optimization program. Cumulative pre-tax charges of $308M from inception (Jan 2020) through Dec 2021. Program completed in Q4 2021. Included in 10-K for context of ongoing integration, though activity occurred in prior years.
2023-12-31restructuringin_progressUSD 78,000,000 (absolute)restructuring_footnote
f5-10k / no-ai-xblr
2023-09-30restructuringin_progress2023-01-01Global (Europe, SSEA CIS & MEA, EA AU & PMI DF, Americas)e-Vapor products (Platform 4) manufacturingUSD 109 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Project to fully outsource and restructure e-vapor device and consumable manufacturing; comprises $78M contract termination charges (including $21M embedded finance lease terminations, payable in cash) and $31M non-cash asset impairments primarily for machinery and equipment. No employee headcount affected was disclosed. Future cash payments substantially by end of 2024, with ~$6M in remainder of 2023; exit cost liability of $36M at 2023-09-30.
2023-09-30restructuringin_progress2023-01-012024-12-31GlobalManufacturingUSD 109 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Project to fully outsource and restructure manufacturing of e-vapor devices and consumables. Includes $78M contract termination costs and $31M asset impairment. Employee count not disclosed.
2023-09-30restructuringin_progressUSD 78,000,000 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2023-06-30restructuringin_progress2023-01-01e-Vapor products manufacturingUSD 109 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Project to fully outsource and restructure manufacturing of e-vapor devices and consumables; charge comprises $78 million contract termination costs (including $21 million embedded finance lease terminations, cash) and $31 million non-cash asset impairments (machinery and equipment). No employee headcount affected was disclosed. Future cash payments expected to be substantially paid by end of 2023.
2023-06-30restructuringin_progress2023-01-012023-12-31GlobalE-vapor manufacturingUSD 109 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Project to fully outsource and restructure e-vapor device and consumable manufacturing; $78M contract termination + $31M asset impairment. No employee count disclosed. Exit cost liability $96M at quarter-end.
2023-06-30acquisition_additioncompleted2022-11-112023-02-17Sweden / United States / InternationalSwedish Match segmentbusiness_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Swedish Match AB acquisition; PMI obtained legal title to 100% of shares on 2023-02-17. No headcount added disclosed in this filing.
2023-06-30divestiture_reductioncompleted2023-06-302023-06-30SwedenSwedish Match — SMD Logistics ABbusiness_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Sale of SMD Logistics AB completed 2023-06-30, required by European Commission as condition of Swedish Match acquisition approval. No headcount reduction disclosed.
2023-06-30restructuringin_progress2023-03-31GlobalManufacturingUSD 109 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Project to fully outsource and restructure manufacturing of e-vapor devices and consumables. Includes $78M contract termination costs and $31M asset impairment. Employee count not disclosed.
2023-06-30restructuringin_progressUSD 78,000,000 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2023-03-31restructuringin_progress2023-01-01Globale-Vapor products manufacturingUSD 109 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Project to fully outsource and restructure manufacturing of e-vapor devices and consumables; includes $78 million contract termination charges (including $21 million embedded finance lease terminations) and $31 million non-cash asset impairments. No employee count disclosed. Future cash payments expected substantially by end of 2023.
2023-03-31acquisition_additioncompleted2022-11-112023-02-17Sweden / United StatesSwedish Match segmentUSD 883 (millions)business_combinations_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
PMI obtained legal title to 100% of Swedish Match shares on February 17, 2023 via compulsory redemption; $883 million paid in Q1 2023 financing activities. No headcount figures disclosed.
2023-03-31restructuringin_progress2023-01-012023-12-31Globale-Vapor Products ManufacturingUSD 109 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Project to fully outsource and restructure e-vapor device and consumable manufacturing. Charge includes $78M contract termination costs (incl. $21M embedded finance lease terminations) and $31M asset impairment. No employee count disclosed. Exit cost liability of $112M at quarter-end; future cash payments expected substantially paid by end of 2023.
2023-03-31acquisition_additioncompleted2022-11-112023-02-17Sweden / InternationalSwedish Match segmentbusiness_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
PMI obtained legal title to 100% of Swedish Match shares on 2023-02-17 via compulsory redemption. No headcount added through the acquisition is disclosed in this filing.
2023-03-31restructuringin_progress2023-03-31GlobalManufacturingUSD 109 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Project to fully outsource and restructure manufacturing of e-vapor devices and consumables. Includes $78M contract termination costs and $31M asset impairment. Employee count not disclosed.
2023-03-31restructuringin_progressUSD 78,000,000 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2022-12-31restructuringcompleted1,0202020-012021-12-31Switzerland; outsourcing also announced in Argentina, Indonesia, Poland and the United StatesOrganizational design optimization of operations center and centralized activitiesUSD 308 (millions)restructuring_footnote
f5-10k / GLM-5.3-flash-HTML
Multi-phase program commenced January 2020 and completed in Q4 2021. Cumulative program-to-date figures as presented in this 10-K: approximately 1,020 positions impacted and $308 million cumulative pre-tax charges through December 31, 2021 ($300 million separation programs, $8 million asset impairments). No new restructuring charges recorded in 2022; 2022 cash payments of $93 million reduced the exit-cost liability from $142 million to $40 million at year-end.
2022-12-31acquisition_additioncompleted2022-05-112022-11-11Global — Sweden-based company with significant U.S. presenceSwedish Match segment (oral nicotine / smoke-free products); 14 owned manufacturing facilities addedbusiness_combinations_footnote
f5-10k / GLM-5.3-flash-HTML
Wholly owned subsidiary PMHH acquired 85.87% of Swedish Match shares on November 11, 2022 (94.81% by December 31, 2022); total consideration $14,460 million ($13,976 million net of cash acquired). Standalone Swedish Match headcount is not disclosed; the consolidated year-end workforce of approximately 79,800 includes Swedish Match employees.
2022-12-31plant_closurein_progress2022-02-25Ukraine (Kharkiv)Eastern Europe segment — manufacturing (Kharkiv factory) and commercial operationsUSD 78 (millions)MD&A
f5-10k / GLM-5.3-flash-HTML
Temporary suspension of commercial and manufacturing operations, including the Kharkiv factory, announced February 25, 2022 to preserve employee safety; production remained suspended at the filing date. No workforce reduction announced — all Ukrainian employees continue to receive salaries. 2022 pre-tax charges of $78 million cover inventory write-downs, receivables allowances and humanitarian costs including salary continuation; approximately $414 million of Ukraine total assets and no long-lived asset impairment recorded as of December 31, 2022.
2022-12-31restructuringin_progress2022-03-24RussiaEastern Europe segment — manufacturing and commercial operationsUSD 73 (millions)MD&A
f5-10k / GLM-5.3-flash-HTML
Steps announced March 24, 2022: suspension of planned investments, scale-down of manufacturing operations, discontinuation of selected cigarette products, suspension of marketing activities, and cancellation of 2022 product launches including ILUMA and related HTU production plans. 2022 pre-tax charges of $73 million reflect machinery and inventory write-downs tied to these commercial decisions. No headcount reduction announced — more than 3,200 Russia-based employees retained with salaries paid; divestment remains constrained by complex Russian regulatory requirements.
2022-12-31voluntary_separationcompletedother
f5-10k / GLM-5.3-flash-HTML
Pension footnote states 2022 settlement and curtailment charges were due primarily to employee severance and early retirement programs (2022 pension settlement/curtailment cost of $2 million; plan asset settlements of $14 million). Affected headcount, program-level charges and completion dates are not disclosed. MD&A notes both the 2022 actual and projected 2023 pension expense figures exclude severance and early retirement program amounts.
2022-12-31acquisition_additioncompleted2022-11-11Global (headquartered in Sweden; significant U.S. presence)Swedish Match segment (oral nicotine / smoke-free)business_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Controlling interest of 85.87% acquired on 2022-11-11, rising to 94.81% by year-end; Swedish Match employees are included in the approximately 79,800 total headcount, but standalone headcount added is not disclosed. Purchase price $14,460 million.
2022-12-31divestiture_reductionin_progressSwedenSwedish Match — SMD Logistics AB (logistics)business_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Divestiture of SMD Logistics AB was required for EC merger approval; assets classified as held for sale at 2022-12-31. Headcount affected not disclosed.
2022-12-31restructuringcompleted2022-12-31GlobalAll segmentsUSD 0 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
No asset impairment or exit cost charges were recorded in FY2022; exit cost liability declined from $142M to $40M via $93M of cash spend on prior-year (2020-2021) programs, including the organizational design optimization completed in Q4 2021 (~1,020 positions cumulative) and the South Korea distribution restructuring. No employees affected in FY2022.
2022-12-31restructuringcompleted1,0202020-01-012021-12-31GlobalOrganizational Design OptimizationUSD 308 (millions)restructuring_footnote
f5-10k / Qwen3.6-27B-Q8_0
Multi-phase restructuring project in Switzerland and outsourcing in Argentina, Indonesia, Poland, and US. Completed in Q4 2021. Cumulative pre-tax charges of $308 million since inception in Jan 2020.
2022-12-31restructuringcompleted2021-01-012021-12-31South KoreaDistributionUSD 57 (millions)restructuring_footnote
f5-10k / Qwen3.6-27B-Q8_0
New business operating model requiring restructuring of distribution agreements. Exit costs related to contract terminations.
2022-12-31restructuringin_progressUSD 0 (absolute)restructuring_footnote
f5-10k / no-ai-xblr
2022-09-30restructuringcompleted1,0202020-01-012021-12-31GlobalOrganizational Design OptimizationUSD 308 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Multi-phase restructuring project commenced in Jan 2020 and completed in Q4 2021. Cumulative pre-tax charges of $308 million related to separation programs ($300M) and asset impairment ($8M). No new charges recorded in Q3 2022.
2022-09-30restructuringin_progressUSD 0 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2022-06-30plant_closurein_progress2022-02-25UkraineEastern EuropeUSD 51 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Operations temporarily suspended including Kharkiv factory closure; six-month 2022 Ukraine charges of $51M pre-tax for inventory write-down, receivables allowance and humanitarian costs including salary continuation
2022-06-30otherannounced2022-03-24RussiaEastern EuropeUSD 71 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Planned orderly exit from Russian market; manufacturing scaled down, marketing suspended, product launches cancelled including IQOS ILUMA and planned TEREA production; six-month 2022 Russia charges of $71M pre-tax, mainly machinery and inventory write-downs
2022-06-30restructuringcompleted1,0202020-01-012021-12-31Switzerland, Argentina, Indonesia, Poland, United StatesOrganizational design optimizationUSD 308 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Multi-phase program completed in Q4 2021; cumulative pre-tax charges of $308M ($300M separation programs, $8M asset impairment); no new charges in 2022; exit cost liability of $90M at June 30, 2022
2022-06-30restructuringin_progress2020-01-012023-12-31GlobalOrganizational Design Optimizationrestructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Multi-phase restructuring project completed in Q4 2021 affecting approx 1,020 positions cumulatively. No new charges recorded in H1 2022. Future cash payments for exit costs incurred to date are anticipated to be substantially paid by the end of 2023.
2022-06-30restructuringin_progressUSD 0 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2022-03-31plant_closurein_progress1,3002022-02-25UkraineEastern EuropeUSD 27 (millions)MD&A
f5-10q / GLM-5.3-flash-fp4-HTML
Temporary suspension of Ukrainian operations including closure of the Kharkiv factory; PMI continues paying salaries to all Ukrainian employees and providing humanitarian support. Pre-tax charge of $27 million covers inventory write-down, receivables allowance and humanitarian costs including salary continuation; not a severance charge. Ukraine headcount disclosed as 'more than 1,300'.
2022-03-31restructuringannounced3,2002022-03-24RussiaEastern EuropeUSD 15 (millions)MD&A
f5-10q / GLM-5.3-flash-fp4-HTML
PMI suspended planned investments, scaled down Russian manufacturing (discontinuing about one-quarter of domestic cigarette SKUs, suspending marketing, cancelling 2022 product launches and the TEREA manufacturing investment of $150 million) and is working on options to exit the Russian market in an orderly manner. Pre-tax charge of $15 million primarily from inventory write-down; not a severance charge. Russia workforce disclosed as 'more than 3,200 people'.
2022-03-31plant_closurein_progress2022-02-25UkraineManufacturingUSD 27 (millions)other
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Operations suspended including Kharkiv factory closure at end of February 2022. $27M pre-tax charge for inventory write-down, receivable allowance, and humanitarian costs including salary continuation for ~1,300 Ukrainian employees. No headcount reduction disclosed.
2022-03-31restructuringannounced2022-03-24RussiaManufacturingUSD 15 (millions)other
f5-10q / MiMo-V2.6-Flash-fp8-HTML
PMI announced suspension of planned investments and plans to scale down Russian manufacturing operations, working on orderly market exit. ~3,200 employees in Russia. $15M pre-tax charge primarily for inventory write-down. No specific headcount reduction disclosed.
2022-03-31restructuringin_progress2020-01-012023-12-31GlobalOrganizational Design OptimizationUSD 0 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Multi-phase restructuring project completed in Q4 2021 impacted approx 1,020 positions cumulatively. No new charges recorded in Q1 2022. Liability balance decreased by $28M cash spent. Future payments expected substantially by end of 2023.
2022-03-31plant_closurein_progress1,3002022-02-25UkraineManufacturingUSD 27 (millions)MD&A
f5-10q / Qwen3.6-27B-Q8_0
Temporarily suspended operations including closing factory in Kharkiv. Charge includes inventory write-down, receivables allowance, and humanitarian efforts including salary continuation for 1,300 employees.
2022-03-31restructuringin_progress3,2002022-03-24RussiaManufacturing and CommercialUSD 15 (millions)MD&A
f5-10q / Qwen3.6-27B-Q8_0
Suspended planned investments and scaled down manufacturing operations. Working on options to exit Russian market. Charge primarily due to inventory write-down. Company continues to pay salaries for 3,200 employees.
2022-03-31restructuringin_progressUSD 0 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2021-12-31restructuringcompleted1,0202020-012021-12-31Primarily Switzerland; outsourcing activities also in Argentina, Indonesia, Poland and the United StatesOperations center and centralized activities (organizational design optimization); charges allocated across all geographical segmentsUSD 159 (millions)restructuring_footnote
f5-10k / GLM-5.3-flash-HTML
Multi-phase restructuring program completed in Q4 2021. Position count of approximately 1,020 is cumulative through fiscal year-end since program inception in January 2020, not FY2021-only. FY2021 charge of $159 million relates to separation programs; cumulative program charges of $308 million ($300 million separation programs, $8 million asset impairment). Included a voluntary separation program in Switzerland. FY2021 separation charges by segment: EU $68M, Eastern Europe $14M, ME&A $17M, S&SA $21M, EA&A $31M, Americas $8M.
2021-12-31restructuringcompleted1,0202020-01-012021-12-31Switzerland (with outsourcing announced in Argentina, Indonesia, Poland and United States)Operations center and centralized activities (organizational design optimization)USD 159 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Multi-phase program commenced January 2020 and completed in Q4 2021. Charge of $159M is the 2021 portion; the ~1,020 positions and $308M cumulative charges ($300M separation, $8M impairment) are cumulative through 2021-12-31, not FY2021-only. Includes a voluntary separation program.
2021-12-31restructuringcompleted2021-01-012021-12-31South KoreaProduct distribution (East Asia & Australia segment)USD 57 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Exit costs for contract terminations and restructuring with certain distributors under a new business operating model commenced in Q1 2021; employee headcount impact not disclosed
2021-12-31acquisition_additioncompleted2021-05-062021-05-06Denmark / SwedenOral tobacco and modern oral (nicotine pouch) products; reported in European Union segmentUSD 28 (millions)business_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Purchase price of $28M cash net of cash acquired plus up to $10M contingent; headcount added not disclosed
2021-12-31acquisition_additioncompleted2021-08-092021-08-09United StatesRespiratory drug development (Other category)USD 38 (millions)business_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Accounted for as an asset acquisition; $38M cash plus transaction costs and contingent payments; a $51M pre-tax charge was recorded to R&D for IPR&D with no alternative future use; headcount added not disclosed
2021-12-31acquisition_additioncompleted2021-09-152021-09-15DenmarkPharmaceutical and well-being products, oral/intra-oral delivery systems (Other category)USD 821 (millions)business_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Total consideration $821M funded with existing cash; headcount added not disclosed
2021-12-31acquisition_additioncompleted2021-09-152021-09-15United KingdomInhaled therapeutics (Other category)USD 1,384 (millions)business_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Controlling 74.77% acquired via open market purchases and tender offer at 165 pence per share, reaching 100% in Q4 2021; total purchase price $1,384M; headcount added not disclosed
2021-12-31otherannounced2021-10-012022-09-30United StatesCorporate headquarters relocation from New York, NY to Stamford, CT (including AMCS headquarters)Item_1_Business
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Announced in Q4 2021, expected completion by Q3 2022; headcount impact and charges not disclosed; announcement date approximate to quarter
2021-12-31restructuringcompleted1,0202020-01-012021-12-31Switzerland, Argentina, Indonesia, Poland, United StatesOperations Center and Centralized ActivitiesUSD 308 (millions)restructuring_footnote
f5-10k / Qwen3.6-27B-Q8_0
Organizational design optimization program. Cumulative pre-tax charges of $308 million from inception in Jan 2020 through Dec 2021. Includes $300 million separation charges and $8 million asset impairment. Program completed in Q4 2021.
2021-12-31restructuringcompleted2021-01-012021-12-31South KoreaDistributionUSD 57 (millions)restructuring_footnote
f5-10k / Qwen3.6-27B-Q8_0
Product distribution restructuring. Exit costs of $57 million recorded in 2021 related to contract terminations and restructuring with certain distributors.
2021-12-31restructuringin_progressUSD 216,000,000 (absolute)restructuring_footnote
f5-10k / no-ai-xblr
2021-09-30restructuringin_progress1502020-01-012021-12-31SwitzerlandOrganizational design optimization (operations center and centralized activities)USD 128 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Multi-phase project begun January 2020; consultation procedures for 2021 phases completed by September 30, 2021, impacting approximately 150 positions. Nine-month 2021 pre-tax charge of $128 million; cumulative program charges of $277 million since inception ($269 million separation programs, $8 million asset impairment). Expected completion in Q4 2021 upon finalization of the voluntary separation program.
2021-09-30voluntary_separationin_progress2020-01-012021-12-31SwitzerlandOrganizational design optimizationrestructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Voluntary separation program in Switzerland for certain eligible employees, launched as part of the multi-phase restructuring project; expected to be finalized in Q4 2021.
2021-09-30restructuringin_progress2021-01-012021-12-31South KoreaProduct distribution restructuring (East Asia & Australia segment)USD 42 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
New business operating model requiring restructuring of current distribution agreements; exit costs of $42 million (nine months) and $16 million (three months) for contract terminations with certain distributors. No employee headcount disclosed; charges relate to distributor contract terminations. Implementation expected to be completed in Q4 2021.
2021-09-30restructuringin_progress1502021-01-012021-12-31SwitzerlandCorporate / centralized activitiesUSD 128 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Multi-phase organizational design optimization; consultation procedures completed by 2021-09-30 impacted approximately 150 positions. Cumulatively about 1,010 positions impacted since 2020 inception with cumulative pre-tax charges of $277 million. Nine-month 2021 pre-tax charges were $128 million ($27 million in Q3). Also includes outsourcing of activities in Argentina, Indonesia, Poland and the United States; expected completion Q4 2021.
2021-09-30restructuringin_progress2021-01-012021-12-31South KoreaEast Asia & Australia — product distributionUSD 42 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
New business operating model requiring restructuring of distribution agreements; exit costs of $42 million for nine months 2021 ($16 million in Q3) from contract terminations with certain distributors. Number of employees affected not disclosed; further exit costs to be recorded as agreements are executed; expected completion Q4 2021.
2021-09-30acquisition_additioncompleted2021-05-062021-05-06DenmarkEuropean Union — oral tobacco / nicotine pouchesbusiness_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Acquisition of 100% of AG Snus Aktieselskab and subsidiary Tobacco House of Sweden AB for $28 million cash plus contingent payments up to $10 million. Headcount added not disclosed.
2021-09-30acquisition_additioncompleted2021-08-092021-08-09United StatesOther — respiratory drug development (OtiTopic)USD 51 (millions)business_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Asset acquisition of OtiTopic, Inc. for $38 million cash plus transaction costs and contingent payments; $51 million pre-tax charge to R&D for IPR&D with no alternative future use. Headcount added not disclosed.
2021-09-30acquisition_additioncompleted2021-09-152021-09-15DenmarkOther — pharmaceutical / oral delivery (Fertin Pharma)business_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Acquisition of 100% of Fertin Pharma A/S for total consideration of $821 million, funded with existing cash. Purchase price allocation preliminary. Headcount added not disclosed.
2021-09-30acquisition_additionin_progress2021-09-152021-12-31United KingdomOther — inhaled therapeutics (Vectura)business_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Acquired controlling interest of 74.77% of Vectura Group plc via open market purchases and tender offer at 165 pence per share, rising to 96.86% by 2021-09-30; compulsory acquisition expected to complete in Q4 2021. Total purchase price $1,383 million for 100% of shares. Headcount added not disclosed.
2021-09-30restructuringin_progress1502021-01-012021-12-31SwitzerlandOperations Center / Centralized ActivitiesUSD 128 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Part of multi-phase organizational design optimization. Consultation procedures for phases commenced in Q1 2021 completed by Sept 30, 2021, impacting approx 150 positions. Cumulative pre-tax charges since inception (2020) are $277 million.
2021-09-30restructuringin_progress2021-01-012021-12-31South KoreaDistributionUSD 42 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Implementation of new business operating model requiring restructuring of current distribution agreements. Exit costs related to contract terminations with certain distributors.
2021-09-30restructuringin_progressUSD 170,000,000 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2021-09-30restructuringin_progress150Switzerland Restructuring, Final Phases [Member]restructuring_footnote
f5-10q / no-ai-xblr
2021-06-30restructuringin_progress9502020-01-012021-12-31Switzerland (with outsourcing activities also in Argentina, Indonesia, Poland and the United States)Operations center and centralized activities; organizational design optimizationUSD 250 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Multi-phase restructuring commenced January 2020; approximately 950 positions impacted since inception through June 30, 2021, with cumulative pre-tax charges of $250 million ($242 million separation program charges and $8 million asset impairment charges). Q2 2021 pre-tax charges of $79 million and YTD charges of $101 million. Includes a voluntary separation program in Switzerland; expected completion in second half of 2021. Potential pension settlement accounting impact not reflected in 2021 as full-year thresholds were not expected to be exceeded as of June 30, 2021.
2021-06-30restructuringin_progress2021-01-012021-12-31South KoreaProduct distribution (East Asia & Australia segment)USD 26 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
New business operating model requires restructuring of current distribution agreements; $26 million of exit costs recorded in Q1 2021 for contract terminations with certain distributors. No employee headcount disclosed; charges relate to distributor contract terminations rather than employee separations. No additional exit costs incurred in Q2 2021; implementation expected to be completed in second half of 2021.
2021-06-30restructuringin_progress9502020-01-012021-12-31Switzerland (with outsourcing in Argentina, Indonesia, Poland, United States)Organizational design optimization — centralized operations and activitiesUSD 250 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Cumulative positions impacted and pre-tax charges since project commencement in January 2020 through June 30, 2021. Approximately 130 positions were impacted by consultation procedures completed in June 2021 (Q2). Cumulative charge comprises $242M separation program charges and $8M asset impairment charges. Includes voluntary separation program in Switzerland and outsourcing announcements. Expected completion in second half of 2021.
2021-06-30restructuringin_progress2021-01-012021-12-31South KoreaProduct distribution — restructuring of distribution agreementsUSD 26 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Exit costs recorded in Q1 2021 for contract terminations with certain distributors under a new business operating model. No employee headcount disclosed. Further exit costs to be recorded as agreements are executed; expected completion in second half of 2021.
2021-06-30acquisition_additioncompleted2021-05-012021-05-31Denmark and SwedenOral tobacco and nicotine pouchesUSD 27 (millions)business_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Acquisition of AG Snus Aktieselskab and subsidiary Tobacco House of Sweden AB for $27M cash net of cash acquired, plus contingent payments up to $10M. No headcount disclosed.
2021-06-30acquisition_additionannounced2021-07-092021-12-31United KingdomInhaled drug delivery / pharmaceutical devicessubsequent_events
f5-10q / MiMo-V2.6-Flash-fp8-HTML
All-cash recommended offer for Vectura Group plc at enterprise value of GBP 852 million (~$1.2B). $1.5B deposited in July 2021 to fund transaction. Expected close in second half of 2021. No headcount disclosed.
2021-06-30acquisition_additionannounced2021-07-012021-12-31Denmark (operations in Denmark, Canada, India)Pharmaceutical and well-being product development and manufacturingsubsequent_events
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Agreement to acquire Fertin Pharma A/S at enterprise value of DKK 5.1 billion (~$820M). Company described as having more than 850 employees. Expected close in Q4 2021. No PMI-side headcount impact disclosed.
2021-06-30restructuringin_progress1302021-03-012021-12-31SwitzerlandOperations Center / Centralized ActivitiesUSD 79 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Consultation procedures completed in June 2021 for phases impacting approx. 130 positions. Part of multi-phase organizational design optimization.
2021-06-30restructuringin_progress2021-01-012021-12-31South KoreaDistributionUSD 26 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Exit costs related to contract terminations with certain distributors. Employee count not explicitly disclosed.
2021-06-30voluntary_separationin_progress2020-01-012021-12-31SwitzerlandVariousrestructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Voluntary separation program launched in Switzerland. Cumulative pre-tax charges of $242M related to separation programs since inception in 2020.
2021-06-30restructuringin_progressUSD 127,000,000 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2021-06-30restructuringin_progress130Switzerland Restructuring, Final Phases [Member]restructuring_footnote
f5-10q / no-ai-xblr
2021-03-31restructuringin_progress2021-01-012021-09-30South KoreaEast Asia & Australia — product distributionUSD 26 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
New business operating model requiring restructuring of distribution agreements; exit costs for contract terminations with certain distributors, no employee headcount disclosed. Implementation expected complete in Q3 2021.
2021-03-31restructuringin_progress2202020-01-012021-06-30SwitzerlandOrganizational design optimization — operations center and centralized activitiesUSD 22 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Final phases of multi-phase restructuring commenced Q1 2021, impacting approximately 220 positions; employee consultation under Swiss law ongoing, costs not yet probable under U.S. GAAP. Q1 2021 charge of $22M covers voluntary separation agreements and outsourcing in other locations.
2021-03-31voluntary_separationin_progress2020-01-01SwitzerlandOrganizational design optimizationUSD 163 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Voluntary separation program for eligible Swiss employees; cumulative separation-program charges of $163M since program inception in 2020 through March 31, 2021. Approximately 750 total positions impacted across the multi-phase program (cumulative pre-tax charges $171M, including $8M asset impairment).
2021-03-31restructuringin_progress2021-01-012021-09-30South KoreaDistributionUSD 26 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
PM Korea began a new business operating model requiring restructuring of distribution agreements; $26M contract termination charges recorded in Q1 2021; further exit costs expected as agreements are executed.
2021-03-31restructuringin_progress2202021-01-012021-06-30SwitzerlandCorporate / Organizational Designrestructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Final phases of multi-phase restructuring commenced in Q1 2021, expected to impact approximately 220 positions; not yet probable under U.S. GAAP so no charge recorded; consultation expected to conclude Q2 2021.
2021-03-31voluntary_separationin_progress2020-01-01Switzerland; Argentina; Indonesia; Poland; United StatesOrganizational Design OptimizationUSD 22 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Q1 2021 charges of $22M for additional voluntary separation agreements in Switzerland and outsourcing of activities in other locations. Cumulative since 2020 inception: approximately 750 positions impacted and $171M in cumulative pre-tax charges ($163M separation, $8M asset impairment).
2021-03-31restructuringin_progress2021-03-312021-09-30South KoreaEast Asia & AustraliaUSD 26 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Implementation of new business operating model requiring restructuring of distribution agreements. Exit costs recorded for contract terminations.
2021-03-31restructuringin_progress2202021-03-312021-06-30SwitzerlandEuropean Unionrestructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Final phases of multi-phase restructuring project commenced. Expected to impact approximately 220 positions. Consultation process expected to complete in Q2 2021.
2021-03-31voluntary_separationin_progress2021-03-31SwitzerlandEuropean Unionrestructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Voluntary separation program launched in Switzerland. Part of organizational design optimization.
2021-03-31restructuringin_progress2021-03-31Argentina, Indonesia, Poland, United StatesOtherrestructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Outsourcing of certain activities announced in Argentina, Indonesia, Poland, and the United States as part of organizational design optimization.
2021-03-31restructuringin_progressUSD 48,000,000 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2021-03-31restructuringin_progress220Switzerland Restructuring, Final Phases [Member]restructuring_footnote
f5-10q / no-ai-xblr
Expected positions to be eliminated
2020-12-31restructuringin_progress6002020-01Switzerland; United States; PolandOperations centers and centralized activities; 2020 charges allocated across all six operating segmentsUSD 149 (millions)restructuring_footnote
f5-10k / GLM-5.3-flash-HTML
Multi-phase organizational design optimization commenced January 2020; consultation procedures for two Swiss phases completed in 2020. A voluntary separation program in Switzerland and outsourcing of activities in the US and Poland are expected to impact approximately 600 positions in total, excluding the third Swiss phase. Pre-tax 2020 charge of $149 million comprises $141 million separation programs and $8 million asset impairment, allocated across all segments (EU $57M, EE $15M, ME&A $19M, S&SA $23M, EA&A $26M, LA&C $9M). Exit-cost cash payments expected to be substantially complete by end of 2022, with approximately $150 million payable in 2021; exit-cost liability of $180 million at December 31, 2020.
2020-12-31restructuringannounced2302021-01SwitzerlandOrganizational design optimization — third phase of the Swiss restructuring projectrestructuring_footnote
f5-10k / GLM-5.3-flash-HTML
Phase three commenced in January 2021, after fiscal year-end. Employee consultation under Swiss law still pending, so the action is not yet probable under U.S. GAAP and total potential costs cannot be determined; no related charge was recorded for 2020.
2020-12-31restructuringin_progress6002020-01Switzerland, United States, PolandOperations center and centralized activities (corporate functions)USD 149 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Multi-phase program commenced January 2020; positions will be eliminated, relocated or outsourced. Consolidated 2020 pre-tax charge of $149M, of which $141M relates to separation programs and $8M to asset impairments. Includes a voluntary separation program in Switzerland and outsourcing of certain activities in the U.S. and Poland. Excludes the third phase (see separate record). Exit cost liability was $180M at year-end, with about $150M expected paid in 2021.
2020-12-31restructuringin_progress2302021-01SwitzerlandOperations center and centralized activities (corporate functions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Third phase of the organizational design program commenced January 2021 (after fiscal year-end). Swiss employee consultation not concluded, so not probable under U.S. GAAP; no 2020 charge recorded and total potential costs not determinable.
2020-12-31restructuringin_progress6002020-01-01Switzerland, United States, PolandOrganizational design optimizationUSD 149 (millions)restructuring_footnote
f5-10k / Qwen3.6-27B-Q8_0
Multi-phase restructuring in Switzerland (2 phases completed in 2020), voluntary separation program in Switzerland, and outsourcing of activities in US and Poland. Excludes 3rd phase of Switzerland project commencing Jan 2021.
2020-12-31plant_closurecompleted2019-11-042020-01-01GermanyEuropean UnionUSD 342 (millions)restructuring_footnote
f5-10k / Qwen3.6-27B-Q8_0
Closure of cigarette plant in Berlin, Germany. Charge recorded in 2019 but production ended Jan 1, 2020.
2020-12-31restructuringin_progressUSD 141,000,000 (absolute)restructuring_footnote
f5-10k / no-ai-xblr
2020-12-31restructuringin_progress230Switzerland Restructuring, Phase 3 [Member]restructuring_footnote
f5-10k / no-ai-xblr
Expected positions to be eliminated
2020-12-31restructuringin_progress600Switzerland Restructuring, Excluding Phase 3 [Member]restructuring_footnote
f5-10k / no-ai-xblr
Expected positions to be eliminated
2020-09-30restructuringin_progress2402020-01-01Switzerland; New York, U.S.A.Operations center and centralized activitiesUSD 71 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
First phase of multi-phase restructuring commenced January 2020 in Switzerland; June 2020 announcement added outsourcing of certain New York activities. Approximately 240 positions to be eliminated, relocated or outsourced. $71 million pre-tax charges recorded in the nine months ended September 30, 2020; no charges in Q3 2020.
2020-09-30voluntary_separationin_progress2020-02-01Switzerlandrestructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Voluntary separation program launched in February 2020 for certain eligible employees in Switzerland.
2020-09-30restructuringannounced2002020-08-01Switzerlandrestructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Second phase of multi-phase restructuring project commenced August 2020; approximately 200 existing positions to be eliminated or relocated. Employee consultation procedure initiated; no related costs recorded as of September 30, 2020. Third phase expected to commence in early 2021.
2020-09-30restructuringin_progress2020-01SwitzerlandCorporate / organizational designrestructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Phase 1 of multi-phase restructuring; consultation completed April 2020, temporarily suspended due to COVID-19, resumed June 2020. Position count not disclosed. Part of $71M YTD pre-tax charge.
2020-09-30voluntary_separationin_progress2020-02SwitzerlandCorporate / organizational designrestructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Voluntary separation program launched for certain eligible employees in Switzerland. Participant count not disclosed.
2020-09-30restructuringin_progress2402020-06United States (New York)Corporate / organizational designrestructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Outsourcing of certain activities in New York; approximately 240 positions to be eliminated, relocated, or outsourced. Charge not separately disclosed.
2020-09-30restructuringin_progress2002020-08SwitzerlandCorporate / organizational designrestructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Phase 2 commenced August 2020; approximately 200 positions to be eliminated or relocated. Employee consultation initiated; no costs recorded as phase not yet probable under U.S. GAAP.
2020-09-30restructuringannounced2020-09-302021SwitzerlandCorporate / organizational designrestructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Phase 3 expected to commence beginning of 2021; not yet considered probable under U.S. GAAP, position count and costs undetermined.
2020-09-30restructuringin_progress2402020-06-01Switzerland, United StatesOperations Center, Centralized ActivitiesUSD 71 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Phase 1 restructuring in Switzerland resumed in June 2020; outsourcing of activities in New York. Positions eliminated, relocated, or outsourced. Pre-tax asset impairment and exit costs of $71 million recorded for the nine months ended Sept 30, 2020.
2020-09-30voluntary_separationcompleted2020-02-01Switzerlandrestructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Voluntary separation program launched in February 2020 for certain eligible employees in Switzerland.
2020-09-30restructuringannounced2002020-08-01Switzerlandrestructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Phase 2 restructuring project commenced in August 2020. Expected to impact approximately 200 existing positions to be eliminated or relocated. No costs recorded as phase not yet probable under U.S. GAAP.
2020-09-30restructuringin_progressUSD 64,000,000 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2020-06-30restructuringin_progress2402020-01-01Switzerland and New York, U.S.A.Organizational design optimization (operations center and centralized activities)USD 71 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Multi-phase project begun January 2020 in Switzerland; temporarily suspended due to COVID-19 and resumed in June 2020 with New York outsourcing announced. Approximately 240 positions to be eliminated, relocated or outsourced. Pension curtailment/settlement impacts not yet reflected as thresholds were not exceeded by June 30, 2020.
2020-06-30restructuringin_progress2402020-06Switzerland; New York, U.S.A.Organizational design optimization (centralized activities)USD 71 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Multi-phase program commenced January 2020 in Switzerland; resumed June 2020 alongside announced outsourcing of certain New York activities. Approximately 240 positions to be eliminated, relocated or outsourced. $71M pre-tax charge recorded for both the three and six months ended June 30, 2020, included in marketing, administration and research costs. Second-phase consultation not yet commenced; no related costs recorded. Pension curtailment/settlement impacts not yet reflected as thresholds not exceeded at June 30, 2020.
2020-06-30plant_closurecompletedColombiaGlobal manufacturing infrastructure optimization (cigarette plant closure)USD 23 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Prior-period plant closure charge of $23M recorded in the three months ended June 30, 2019 (comparative period); included for context of ongoing global manufacturing footprint optimization. No employee count disclosed.
2020-06-30restructuringin_progress2402020-06-302021-12-31Switzerland; New York, U.S.A.Organizational Design OptimizationUSD 71 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
PMI resumed restructuring activities in Switzerland and announced outsourcing of certain activities in New York. Activities expected to impact approximately 240 positions to be eliminated, relocated or outsourced. Pre-tax asset impairment and exit costs of $71 million recorded for six and three months ended June 30, 2020. Future cash payments anticipated to be substantially paid by end of 2021.
2020-06-30restructuringin_progress240restructuring_footnote
f5-10q / no-ai-xblr
Expected positions to be eliminated
2020-03-31restructuringannounced2020-01SwitzerlandOrganizational design optimization (relocation and outsourcing of certain activities)MD&A
f5-10q / GLM-5.3-flash-fp4-HTML
Two-phase restructuring project; first-phase employee consultation completed April 2020, but management suspended restructuring plans due to COVID-19; no amounts recorded in Q1 2020 as exit activity not considered probable under U.S. GAAP as of March 31, 2020.
2020-03-31restructuringin_progress20192021-12-31Argentina, Colombia, Germany, PakistanGlobal Manufacturing Infrastructure OptimizationUSD 140 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Exit cost liability of $140 million at March 31, 2020 (from $191 million at January 1, 2020; $48 million cash spent in Q1 2020); no new pre-tax charges recorded in Q1 2020. Future payments substantially by end of 2021, with approximately $66 million expected in remainder of 2020. Q1 2019 included a $20 million charge for the Pakistan plant closure.
2020-03-31restructuringin_progress2020-01-31SwitzerlandCorporate / Organizational DesignMD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Two-phase restructuring project commenced January 2020; first-phase employee consultation completed April 2020 but plans suspended due to COVID-19. No charge recorded in Q1 2020 as exit activity not considered probable. No employee count disclosed.
2020-03-31restructuringannounced2020-01-01SwitzerlandCorporateMD&A
f5-10q / Qwen3.6-27B-Q8_0
PMI commenced a two-phase restructuring project in Switzerland in January 2020. Employee consultation was completed in April 2020, but management suspended restructuring plans due to the COVID-19 pandemic. No amounts were recorded in Q1 2020 as the exit activity was not considered probable.
2019-12-31plant_closurecompleted2019-11-042020-01-01GermanyEuropean UnionUSD 342 (millions)restructuring_footnote
f5-10k / GLM-5.3-flash-HTML
German affiliate agreed with employee representatives to end cigarette production at the Berlin factory by January 1, 2020. Total pre-tax charge of $342M comprises $251M pension and employee separation costs (cash) and $91M non-cash asset impairment, primarily machinery and equipment. Separation cash to be substantially paid by end of 2021, with roughly $115M expected in 2020. Affected headcount not quantified.
2019-12-31plant_closurecompletedArgentinaLatin America & CanadaUSD 15 (millions)restructuring_footnote
f5-10k / GLM-5.3-flash-HTML
Cigarette plant closure recorded in 2019 as part of global manufacturing infrastructure optimization; total pre-tax asset impairment and exit costs of $15M.
2019-12-31plant_closurecompletedColombiaLatin America & CanadaUSD 45 (millions)restructuring_footnote
f5-10k / GLM-5.3-flash-HTML
Cigarette plant closure recorded in 2019 as part of global manufacturing infrastructure optimization; total pre-tax asset impairment and exit costs of $45M.
2019-12-31plant_closurecompletedPakistanSouth & Southeast AsiaUSD 20 (millions)restructuring_footnote
f5-10k / GLM-5.3-flash-HTML
Cigarette plant closure with pre-tax asset impairment and exit costs of $20M; segment commentary indicates the charge was recorded in the first quarter of 2019.
2019-12-31restructuringannounced2652020-01SwitzerlandEuropean UnionMD&A
f5-10k / GLM-5.3-flash-HTML
First phase of a two-phase organizational design restructuring; approximately 265 positions may be eliminated or relocated, with employee consultation procedures initiated as required by law. Second phase expected to commence in the second quarter of 2020. Disclosed as a subsequent event; no associated charge yet quantified.
2019-12-31plant_closurein_progress2019-11-042020-01-01Germany (Berlin)European Union — manufacturingUSD 251 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Agreement with employee representatives to end cigarette production at the Berlin factory by January 1, 2020. Total pre-tax charge of $342 million comprises $251 million pension and employee separation costs (cash) and $91 million non-cash asset impairment. Position counts not disclosed.
2019-12-31plant_closurecompletedArgentinaLatin America & Canada — manufacturingUSD 15 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Cigarette plant closure recorded during 2019 as part of global manufacturing infrastructure optimization. Country-level split between separation and impairment components not disclosed; segment totals for Latin America & Canada were $49 million separation and $11 million impairment (Argentina and Colombia combined).
2019-12-31plant_closurecompletedColombiaLatin America & Canada — manufacturingUSD 45 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Cigarette plant closure recorded during 2019 as part of global manufacturing infrastructure optimization. Country-level split between separation and impairment components not disclosed.
2019-12-31plant_closurecompletedPakistanSouth & Southeast Asia — manufacturingUSD 20 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Cigarette plant closure recorded in Q1 2019; comprises $3 million separation and $17 million asset impairment per the segment table.
2019-12-31restructuringannounced2652020-01SwitzerlandCorporate / organizational designsubsequent_events
f5-10k / MiMo-V2.6-Flash-fp8-HTML
First phase of a two-phase restructuring project commenced January 2020 (after fiscal year-end); may impact approximately 265 existing positions to be eliminated or relocated, with consultation procedures initiated. Second phase expected to commence in Q2 2020; no charge quantified.
2019-12-31othercompleted2019-03-222019-03-22CanadaLatin America & Canadaother
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Rothmans, Benson & Hedges Inc. deconsolidated on March 22, 2019 following CCAA protection, removing its workforce from consolidated headcount. RBH headcount not disclosed; PMI continues to report volume of certain RBH-sold brands. A $194 million pre-tax Canadian tobacco litigation charge and $239 million loss on deconsolidation were recorded in 2019.
2019-12-31restructuringin_progress2019-11-042020-01-01GermanyEuropean UnionUSD 342 (millions)restructuring_footnote
f5-10k / Qwen3.6-27B-Q8_0
Closure of cigarette plant in Berlin. Charge includes $251M pension/employee separation and $91M asset impairment.
2019-12-31restructuringcompleted2019-01-012019-12-31ArgentinaLatin America & CanadaUSD 15 (millions)restructuring_footnote
f5-10k / Qwen3.6-27B-Q8_0
Closure of cigarette plant.
2019-12-31restructuringcompleted2019-01-012019-12-31ColombiaLatin America & CanadaUSD 45 (millions)restructuring_footnote
f5-10k / Qwen3.6-27B-Q8_0
Closure of cigarette plant.
2019-12-31restructuringcompleted2019-01-012019-03-31PakistanSouth & Southeast AsiaUSD 20 (millions)restructuring_footnote
f5-10k / Qwen3.6-27B-Q8_0
Closure of cigarette plant in first quarter.
2019-09-30plant_closurein_progress2019-12-31ColombiaLatin America & CanadaUSD 45 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Cigarette plant closure in Colombia; $45M of the $65M nine-month charge; additional ~$4M exit costs expected in remainder of 2019; $22M of the charge was recorded in Q3 2019.
2019-09-30plant_closurein_progressPakistanSouth & Southeast AsiaUSD 20 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Cigarette plant closure in Pakistan; $20M pre-tax charge recorded in Q1 2019 as part of global manufacturing infrastructure optimization.
2019-09-30plant_closureannounced2019-04-012020-01-01GermanyEuropean Unionrestructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Philip Morris Manufacturing GmbH proposal to end cigarette production at Berlin factory by January 1, 2020; consultations with employee representatives initiated in Q2 2019; closure not yet probable under U.S. GAAP, so no costs recorded in Q3 2019; expected costs significant, including severance, accelerated depreciation and impairment.
2019-09-30plant_closurein_progressPakistanSouth & Southeast Asia — cigarette manufacturingUSD 20 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Cigarette plant closure recorded within nine-month pre-tax exit costs; part of global manufacturing infrastructure optimization. No employee count or completion date disclosed.
2019-09-30plant_closurein_progressColombiaLatin America & Canada — cigarette manufacturingUSD 45 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Nine-month pre-tax charge of $45M, of which $22M was recorded in Q3 2019; an additional ~$4M of exit costs expected during the remainder of 2019. No employee count disclosed.
2019-09-30plant_closureannounced2020-01-01Germany (Berlin)Philip Morris Manufacturing GmbH — cigarette productionrestructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Consultations with employee representatives initiated in Q2 2019 on ending cigarette production at the Berlin factory by January 1, 2020. Closure not yet probable under U.S. GAAP, so no costs recorded in Q3 2019; potential costs expected to be significant but not determinable. Announcement date known only to the quarter.
2019-09-30divestiture_reductioncompleted2019-03-222019-03-22CanadaLatin America & Canada — Rothmans, Benson & Hedges Inc. (RBH)other
f5-10q / MiMo-V2.6-Flash-fp8-HTML
RBH deconsolidated from PMI's financial statements upon its CCAA filing, removing its workforce from PMI's consolidated headcount. No employee count disclosed; $239M pre-tax loss on deconsolidation recorded, not a severance charge.
2019-09-30plant_closurein_progress2019-04-012020-01-01GermanyManufacturingrestructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Consultations initiated in Q2 2019 to end cigarette production in Berlin factory by Jan 1, 2020. Closure not yet considered probable under US GAAP; no costs recorded in Q3. Total potential costs expected to be significant.
2019-09-30plant_closurecompletedPakistanManufacturingUSD 20 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Pre-tax asset impairment and exit costs of $20 million recorded for nine months ended Sept 30, 2019 related to cigarette plant closure.
2019-09-30plant_closurein_progressColombiaManufacturingUSD 45 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Pre-tax asset impairment and exit costs of $45 million recorded for nine months ended Sept 30, 2019 related to cigarette plant closure. Additional pre-tax exit costs of approx $4 million expected in remainder of 2019.
2019-06-30plant_closurecompletedPakistanSouth & Southeast Asia - cigarette manufacturingUSD 20 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Cigarette plant closure in Pakistan recorded in the three months ended March 31, 2019; part of $43 million six-month total, with $20 million attributable to this closure (six-month total less $23 million Q2 Colombia charge).
2019-06-30plant_closurein_progress2019-12-31ColombiaLatin America & Canada - cigarette manufacturingUSD 23 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Cigarette plant closure in Colombia recorded in the three months ended June 30, 2019; approximately $30 million of additional pre-tax exit costs expected during the remainder of 2019.
2019-06-30plant_closureannounced2019-04-012020-01-01Berlin, GermanyEuropean Union - cigarette manufacturingrestructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
PMMG initiated consultations with employee representatives on a proposal to end cigarette production in its Berlin factory by January 1, 2020; closure not considered probable until consultations conclude, so no related costs were recorded in Q2 2019.
2019-06-30plant_closurecompletedPakistanManufacturing — South & Southeast Asiarestructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Cigarette plant closure occurred in Q1 2019 as part of global manufacturing infrastructure optimization; no employee count or separate charge disclosed for this site.
2019-06-30plant_closurecompletedColombiaManufacturing — Latin America & Canadarestructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Cigarette plant closure occurred in Q2 2019; additional pre-tax exit costs of approximately $30 million expected during remainder of 2019. No employee count disclosed.
2019-06-30plant_closureannounced2019-04-012020-01-01Germany (Berlin)Manufacturing — European Unionrestructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Philip Morris Manufacturing GmbH initiated consultations with employee representatives in Q2 2019 on a proposal to end cigarette production at its Berlin factory by January 1, 2020. Closure not yet considered probable; no charge recorded and no employee count disclosed.
2019-06-30divestiture_reductioncompleted2019-03-222019-03-22CanadaLatin America & Canadaother
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Rothmans, Benson & Hedges Inc. deconsolidated effective March 22, 2019 following CCAA filing; RBH employees no longer consolidated in PMI headcount. No employee count disclosed.
2019-06-30plant_closurein_progress2019-03-312019-12-31PakistanSouth & Southeast Asiarestructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Cigarette plant closure in Pakistan recorded in Q1 2019. Part of global manufacturing infrastructure optimization.
2019-06-30plant_closurein_progress2019-06-302019-12-31ColombiaLatin America & CanadaUSD 23 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Cigarette plant closure in Colombia recorded in Q2 2019. Pre-tax asset impairment and exit costs of $23 million recorded in Q2. Additional pre-tax exit costs of approx $30 million expected in remainder of 2019.
2019-06-30plant_closureannounced2019-06-302020-01-01GermanyEuropean Unionrestructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Philip Morris Manufacturing GmbH initiated consultations to end cigarette production in Berlin factory by Jan 1, 2020. Closure not considered probable; no costs recorded.
2019-03-31plant_closurein_progressPakistanSouth & Southeast AsiaUSD 20 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Pre-tax asset impairment and exit costs of $20 million for Q1 2019 related to a plant closure in Pakistan as part of global manufacturing footprint optimization; charge recorded in marketing, administration and research costs. No employee count disclosed.
2019-03-31divestiture_reductioncompleted2019-03-22CanadaLatin America & CanadaUSD 239 (millions)other
f5-10q / GLM-5.3-flash-fp4-HTML
PMI deconsolidated Canadian subsidiary Rothmans, Benson & Hedges Inc. as of the CCAA filing date of March 22, 2019, after the Ontario Superior Court granted creditor protection; RBH removed from consolidated balance sheet and accounted for as an equity security at fair value of $3,280 million. Loss on deconsolidation of $239 million pre-tax. No headcount figures disclosed.
2019-03-31plant_closurein_progressPakistanSouth & Southeast Asia — manufacturingUSD 20 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Plant closure in Pakistan as part of global manufacturing footprint optimization; $20M pre-tax charge recorded in Q1 2019. No employee count disclosed.
2019-03-31divestiture_reductioncompleted2019-03-222019-03-22CanadaLatin America & Canada — Rothmans, Benson & Hedges Inc.USD 239 (millions)other
f5-10q / MiMo-V2.6-Flash-fp8-HTML
RBH obtained CCAA protection on 2019-03-22; PMI deconsolidated RBH as of that date. $239M pre-tax loss on deconsolidation. No employee count disclosed.
2019-03-31plant_closurecompletedPakistanSouth & Southeast AsiaUSD 20 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Pre-tax asset impairment and exit costs of $20 million recorded related to a plant closure in Pakistan as part of global manufacturing footprint optimization. Employee count not disclosed.
2018-12-31acquisition_additioncompleted2018-03-212018-03-21Costa RicaLatin America & CanadaUSD 95 (millions)business_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Purchase of the remaining 49% interest in Tabacalera Costarricense, S.A. and Mendiola y Compañía, S.A. for a net purchase price of $95 million (including $2 million contingent consideration); no headcount added through the transaction is disclosed.
2016-12-31restructuringin_progress2015-112017-12European UnionEuropean Union segment — organizational restructuringUSD 93 (millions)restructuring_footnote
f5-10k / GLM-5.3-flash-HTML
Program commenced November 2015, expected completion by end of 2017. Charge is cumulative through fiscal year-end: ~$93 million pre-tax program total per Item 7 ($68 million 2015 employee separation/severance costs plus up to $25 million implementation costs). No new asset impairment or exit-cost charges were recorded in 2016; combined PMI exit-cost cash payments in 2016 were $31 million, and the remaining exit-cost liability of $19 million at December 31, 2016 is expected to be substantially paid by end of 2017. Number of employees affected is not disclosed. No other workforce actions (RIFs, layoffs, acquisitions, divestitures, or plant closures) were attributed to fiscal 2016; the Bergen op Zoom, Netherlands factory closure program was substantially completed as of December 31, 2015 and is therefore excluded as prior-year activity.
2016-12-31restructuringin_progress2015-112017-12-31European UnionEuropean Union segment — organizational restructuringUSD 93 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Cumulative program charge of approximately $93 million pre-tax; $68 million of severance was recorded in 2015 and no charge was recorded in 2016. Exit cost liability of $19 million remained at 2016-12-31, with $31 million of cash payments made during 2016. Employees affected not disclosed.
2016-12-31restructuringin_progress2015-11-012017-12-31European UnionEuropean Union SegmentUSD 68 (millions)restructuring_footnote
f5-10k / Qwen3.6-27B-Q8_0
Program commenced in Nov 2015. 2016 charges were $0; 2015 pre-tax exit costs were $68M related to employee separation. Total program charge approx $93M.
2016-12-31restructuringin_progressUSD 0 (absolute)restructuring_footnote
f5-10k / no-ai-xblr
2016-09-30restructuringin_progress2015-11-012017-12-31European UnionEuropean Union segmentUSD 93 (millions)MD&A
f5-10q / GLM-5.3-flash-fp4-HTML
EU restructuring program commenced November 2015; total expected pre-tax charge approximately $93 million, of which $68 million in employee separation costs was recorded in 2015 and up to $25 million in implementation costs to be reflected in cost of sales and marketing, administration and research costs. No employee headcount affected was disclosed in this filing.
2016-09-30restructuringin_progress2015-112017-12-31European UnionEuropean Union segmentUSD 93 (millions)MD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Program announced Nov 2015; $68M of employee separation exit costs recorded in 2015, plus up to $25M implementation costs. No employee count disclosed; no charges incurred in Q3 2016.
2016-09-30restructuringin_progress2015-11-012017-12-31European UnionEuropean Union SegmentUSD 93 (millions)MD&A
f5-10q / Qwen3.6-27B-Q8_0
Program commenced in Nov 2015. Total pre-tax charge expected to be approx $93 million. $68 million recorded in 2015 for employee separation costs. Up to $25 million for implementation costs.
2016-09-30restructuringin_progressUSD 0 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2016-06-30restructuringin_progress2015-11-012017-12-31European UnionEuropean Union segmentUSD 93 (millions)MD&A
f5-10q / GLM-5.3-flash-fp4-HTML
EU restructuring program commenced November 2015; total expected pre-tax charge approximately $93 million, of which $68 million in employee separation costs was recorded in 2015 and up to $25 million in implementation costs (project team and notice period payments) to be reflected in cost of sales and marketing, administration and research costs. No employee headcount affected was disclosed.
2016-06-30restructuringin_progress2015-11-012017-12-31European UnionEuropean Union segmentUSD 93 (millions)MD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML
EU restructuring program announced Nov 2015; $68M exit costs recorded in 2015, up to $25M implementation costs to follow. No employee count disclosed. Exit cost liability fell from $54M to $32M during H1 2016 with $22M cash spent.
2016-06-30restructuringin_progress2015-11-012017-12-31European UnionEuropean Union SegmentUSD 93 (millions)MD&A
f5-10q / Qwen3.6-27B-Q8_0
Program commenced in Nov 2015. Total pre-tax charge expected to be approx $93 million. $68 million recorded in 2015 for employee separation costs. Up to $25 million for implementation costs (project team, notice periods) reflected in cost of sales and marketing/admin/research costs.
2016-06-30restructuringin_progressUSD 0 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2016-03-31restructuringin_progress2015-11-012017-12-31European UnionEuropean Union segmentUSD 93 (millions)MD&A
f5-10q / GLM-5.3-flash-fp4-HTML
EU restructuring program announced November 2015; total expected pre-tax charge approximately $93 million, of which $68 million in employee separation costs was recorded in 2015 and up to $25 million of implementation costs to be reflected in cost of sales and marketing, administration and research costs. No employee count disclosed. Exit cost liability was $54 million at January 1, 2016 and $42 million at March 31, 2016, with $14 million of cash spent in the quarter.
2016-03-31restructuringin_progress2015-11-012017-12-31European UnionEuropean Union segmentUSD 93 (millions)MD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Program announced November 2015; $68M exit costs recorded in 2015 for employee separations, plus up to $25M implementation costs. No employee count disclosed. Q1 2016 exit cost liability rolled from $54M to $42M with $14M cash spent; no new charges in the quarter.
2016-03-31restructuringin_progress2015-11-012017-12-31European UnionEuropean Union SegmentUSD 93 (millions)MD&A
f5-10q / Qwen3.6-27B-Q8_0
Program commenced in Nov 2015. Total pre-tax charge expected to be approx $93 million. $68 million recorded in 2015 for employee separation costs. Up to $25 million for implementation costs.
2016-03-31restructuringin_progressUSD 0 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2015-12-31restructuringin_progress2015-112017-12-31European UnionEuropean Union segmentUSD 68 (millions)restructuring_footnote
f5-10k / GLM-5.3-flash-HTML
Program commenced November 2015; $68 million pre-tax employee separation costs recorded in 2015. Total expected program charge approximately $93 million, including up to $25 million implementation costs in cost of sales and marketing/administration. Headcount affected not quantified.
2015-12-31plant_closurecompleted2014-04-042015-12-31Netherlands (Bergen op Zoom)European Union segmentUSD 549 (millions)restructuring_footnote
f5-10k / GLM-5.3-flash-HTML
Cumulative program charge through fiscal 2015; $489 million recorded in 2014, including $343 million employee separation costs and $139 million asset impairment. Cigarette production ceased September 1, 2014 following agreement with trade unions; program substantially completed as of December 31, 2015. Headcount affected not quantified.
2015-12-31restructuringin_progress2015-112017-12-31European UnionEuropean Union segment — organizational restructuringUSD 68 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Program commenced November 2015; $68M of pre-tax exit costs for employee separations recorded in FY2015. Total program expected to incur approximately $93M pre-tax, including up to $25M of implementation costs recorded in cost of sales and marketing, administration and research costs. Employees affected not disclosed.
2015-12-31restructuringin_progress2015-11-012017-12-31European UnionEuropean Union RegionUSD 68 (millions)restructuring_footnote
f5-10k / Qwen3.6-27B-Q8_0
Program commenced in November 2015. Total expected pre-tax charge is approximately $93 million. $68 million recorded in 2015 related to employee separation costs.
2015-12-31plant_closurecompleted2014-04-042014-09-01NetherlandsEuropean Union RegionUSD 489 (millions)restructuring_footnote
f5-10k / Qwen3.6-27B-Q8_0
Discontinuation of cigarette production at Bergen op Zoom factory. Production ceased Sept 1, 2014. Program substantially completed as of Dec 31, 2015. Charge includes $343M employee separation, $139M asset impairment, $7M other separation.
2015-12-31restructuringin_progressUSD 68,000,000 (absolute)restructuring_footnote
f5-10k / no-ai-xblr
2015-09-30plant_closurecompleted2014-04-042014-09-01NetherlandsEuropean UnionUSD 472 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Cigarette production at Bergen op Zoom factory ceased September 1, 2014 after agreement with trade unions on a social plan; charge includes $343M employee separation costs and $129M asset impairment. Total program cost approximately $549 million including implementation costs. No employee counts disclosed.
2015-09-30plant_closurecompleted2014-01-01AustraliaAsiaUSD 24 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Factory closure severance costs recorded in 2014; no employee counts disclosed.
2015-09-30plant_closurecompleted2014-01-01CanadaLatin America & CanadaUSD 7 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Severance costs of $3 million plus asset impairment charges of $4 million recorded in 2014 for a factory closure in Canada; no employee counts disclosed.
2015-09-30restructuringcompleted2014-04-042015-12-31NetherlandsEuropean UnionUSD 472 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Discontinuation of cigarette production at Bergen op Zoom factory. Production ceased Sept 1, 2014. Pre-tax charges of $472M recorded in 2014 (including $343M employee separation). Future cash payments for exit costs incurred to date expected to be approx $36M, substantially paid by end of 2015.
2015-09-30restructuringcompletedAustralia and CanadaAsia and Latin America & CanadaUSD 27 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Other pre-tax separation program charges of $27M for nine months ended Sept 30, 2014 related to severance costs for factory closures.
2015-09-30restructuringin_progressUSD 0 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2015-06-30plant_closurecompleted2014-04-042014-09-01Netherlands (Bergen op Zoom)European UnionUSD 488 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Cigarette production ceased September 1, 2014 after agreement with trade unions on a social plan. Charges recorded in 2014: $359M employee separation costs and $129M asset impairment. No charges in 2015; remaining exit cost liability of $52M at June 30, 2015, with $204M cash paid in H1 2015.
2015-06-30plant_closurecompleted2014-01-01AustraliaAsiaUSD 24 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Severance costs for a factory closure in Australia; charges of $24M (six months) and $1M (three months) recorded in 2014. No charges in 2015.
2015-06-30restructuringin_progress2014-04-042015-12-31NetherlandsEuropean UnionUSD 204 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Cash payments related to exit costs for the six months ended June 30, 2015 were $204 million. Future cash payments expected to be approximately $52 million, substantially paid by end of 2015. Program involves discontinuation of cigarette production at Bergen op Zoom factory.
2015-06-30restructuringin_progressUSD 0 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2015-03-31plant_closurecompleted2014-04-042015-12-31NetherlandsEuropean UnionUSD 547 (millions)MD&A
f5-10q / GLM-5.3-flash-fp4-HTML
Cigarette production at Bergen op Zoom ceased September 1, 2014 after agreement on a social plan with unions; total expected pre-tax charge approximately $547 million, of which $489 million recorded in 2014; cash expenditures expected substantially by end of 2015.
2015-03-31plant_closurecompleted2014-01-012014-12-31AustraliaAsiaUSD 23 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Decision in Q1 2014 to cease Australian cigarette production by end of 2014 and transition production to South Korea; severance charges of $23 million pre-tax recorded in Q1 2014; no charges in Q1 2015.
2015-03-31plant_closurein_progress2014-04-042015-12-31NetherlandsManufacturing — Bergen op Zoom factoryUSD 547 (millions)MD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Cigarette production ceased 2014-09-01. Total expected pre-tax charge ~$547M; $489M recorded in 2014. Remaining exit cost payments expected by end of 2015. No employee count disclosed in this filing.
2015-03-31plant_closurecompleted2014-01-012014-12-31AustraliaManufacturing — factory closureUSD 23 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Pre-tax severance charge of $23M recorded in Q1 2014 for Australian factory closure; production transitioned to South Korea affiliate by end of 2014. No employee count disclosed.
2015-03-31restructuringin_progress2014-04-042015-12-31NetherlandsManufacturingUSD 547 (millions)MD&A
f5-10q / Qwen3.6-27B-Q8_0
Program to discontinue cigarette production at Bergen op Zoom factory. Total pre-tax charge approx $547M. Substantially all cash expenditures expected to be paid by end of 2015. No specific employee count disclosed in this filing.
2015-03-31restructuringcompleted2014-01-012014-12-31AustraliaManufacturingUSD 23 (millions)MD&A
f5-10q / Qwen3.6-27B-Q8_0
Ceased cigarette production in Australia by end of 2014. Pre-tax asset impairment and exit costs of $23M recorded in Q1 2014 related to severance costs. No specific employee count disclosed in this filing.
2015-03-31restructuringin_progressUSD 0 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2014-12-31plant_closurecompleted2014-04-042014-09-01Netherlands (Bergen op Zoom)European UnionUSD 343 (millions)restructuring_footnote
f5-10k / GLM-5.3-flash-HTML
Consultations announced 2014-04-04; agreement reached with trade unions on a social plan and cigarette production ceased 2014-09-01. Pre-tax costs of $489M recorded in 2014 comprise $343M employee separation costs, $139M asset impairment and $7M other separation costs; total expected pre-tax program charge approximately $547M, including up to $58M of implementation costs (primarily notice-period payments), with cash expenditures expected substantially by end of 2015. No employee count disclosed.
2014-12-31plant_closurecompletedAustraliaAsiarestructuring_footnote
f5-10k / GLM-5.3-flash-HTML
Cited among the primary drivers of 2014 asset impairment and exit costs ($535M total). Note 5 reports Asia-segment separation program charges of $35M in 2014, and the Asia segment MD&A attributes an $8M year-over-year increase in exit costs principally to this closure. No employee count or program-specific charge disclosed.
2014-12-31plant_closurecompletedCanadaLatin America & CanadaUSD 5 (millions)restructuring_footnote
f5-10k / GLM-5.3-flash-HTML
Note 5 states $5M of 2014 asset impairment charges related to this closure; related severance costs formed part of approximately $41M of 2014 other separation charges shared with the Australia closure and the U.S. leaf purchasing model restructuring. No employee count disclosed.
2014-12-31restructuringin_progressUnited StatesLeaf purchasingrestructuring_footnote
f5-10k / GLM-5.3-flash-HTML
Restructuring of the U.S. leaf purchasing model cited among primary drivers of 2014 separation charges; its severance costs are included in approximately $41M of 2014 other separation charges shared with the Australia and Canada factory closures. No employee count or completion timeline disclosed.
2014-12-31plant_closurecompleted2014-04-042015-12-31NetherlandsEuropean Union — cigarette manufacturing (Bergen op Zoom factory)USD 489 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Pre-tax charge recorded in 2014 comprises $343M employee separation, $139M asset impairment and $7M other separation costs; total program estimated at approximately $547M plus up to $58M of implementation costs recorded in operating expense. Cigarette production ceased 2014-09-01; substantially all remaining exit cash payments expected by end of 2015. Headcount affected not disclosed.
2014-12-31restructuringcompletedAustralia, Canada, United StatesManufacturing (factory closures in Australia and Canada) and leaf purchasing (U.S. leaf purchasing model)USD 41 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Consolidated 2014 other pre-tax separation program charges of $41M, primarily severance for the Australia and Canada factory closures and the U.S. leaf purchasing model restructuring; filer does not break out counts or charges by component. A separate $5M asset impairment was recorded for the Canada factory closure.
2014-12-31acquisition_additioncompleted2014-06-302014-06-30United KingdomE-vapor business (Nicocigs Limited / Nicolites)business_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
100% of Nicocigs Limited acquired June 2014 for a final purchase price of $103M net of cash acquired, with contingent payments of up to $77M (projected up to $62M over the remaining two-year period as of 2014-12-31). Acquired headcount not disclosed; announcement month stated as June 2014 (day not specified).
2014-12-31plant_closurecompleted2014-04-042014-09-01NetherlandsEuropean UnionUSD 489 (millions)MD&A
f5-10k / Qwen3.6-27B-Q8_0
Discontinuation of cigarette production at Bergen op Zoom factory. Pre-tax charge includes employee separation costs of $343 million, asset impairment of $139 million, and other separation costs of $7 million.
2014-12-31restructuringcompletedAustraliaAsiaMD&A
f5-10k / Qwen3.6-27B-Q8_0
Factory closure in Australia included in 2014 pre-tax asset impairment and exit costs.
2014-12-31restructuringcompletedCanadaLatin America & CanadaMD&A
f5-10k / Qwen3.6-27B-Q8_0
Factory closure in Canada included in 2014 pre-tax asset impairment and exit costs.
2014-12-31restructuringcompletedUnited StatesCorporateMD&A
f5-10k / Qwen3.6-27B-Q8_0
Restructuring of the U.S. leaf purchasing model included in 2014 pre-tax asset impairment and exit costs.
2014-12-31restructuringin_progressUSD 391,000,000 (absolute)restructuring_footnote
f5-10k / no-ai-xblr
2014-09-30plant_closurecompleted2014-04-042015-09-30NetherlandsEuropean UnionUSD 472 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Cigarette production at Bergen op Zoom factory ceased September 1, 2014 after agreement on a social plan with trade unions. Total program pre-tax charge expected at approximately $542 million, including $343 million employee separation costs and $129 million asset impairment; up to $70 million implementation costs to be reflected in cost of sales and MA&R. YTD charge of $472 million is net of a $16 million third-quarter reversal due to a change in estimate. Cash expenditures substantially complete by Q3 2015.
2014-09-30plant_closurein_progress2014-01-012014-12-31AustraliaAsiaUSD 24 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Decision to discontinue cigarette production in Australia by end of 2014; severance costs for factory closure recorded in the nine months ended September 30, 2014. After-tax EPS impact of $0.01 recorded in Q1 2014 with an anticipated $0.01 in Q4 2014.
2014-09-30plant_closurein_progress2014-01-01CanadaLatin America & CanadaUSD 11 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Leaf processing facility closure in Canada: $4 million asset impairment charge plus $3 million severance costs in the nine months ended September 30, 2014; MD&A separately cites a $7 million pre-tax exit cost charge for the facility closure in the LA&C segment.
2014-09-30plant_closurecompleted2014-04-042014-09-01NetherlandsEuropean Union — cigarette manufacturing (Bergen op Zoom factory)USD 542 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Total program charge of ~$542M pre-tax, including $343M employee separation costs and $129M asset impairment; up to $70M additional implementation costs in cost of sales and M&A&R. Production ceased 2014-09-01 after social plan agreement with trade unions. No employee headcount disclosed.
2014-09-30plant_closurein_progress2014-12-31AustraliaAsia — cigarette manufacturingUSD 24 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Separation program charges of $24M for nine months ended 2014-09-30 related to severance for factory closure; decision to discontinue cigarette production by end of 2014. No employee headcount disclosed.
2014-09-30plant_closurein_progressCanadaLatin America & Canada — factory and leaf processing facility closuresUSD 7 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Separation program charges of $3M and asset impairment charges of $4M for nine months ended 2014-09-30 related to factory closure and leaf processing facility closure. No employee headcount disclosed.
2014-09-30acquisition_additioncompleted2014-06-302014-06-30United KingdomE-vapor (Nicocigs Limited)USD 103 (millions)business_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Acquired 100% of Nicocigs Limited for $103M net of cash acquired, plus contingent payments up to $77M. Purchase price allocation expected to be completed by end of 2014. No headcount added disclosed.
2014-09-30plant_closurecompleted2014-04-042015-09-30NetherlandsEuropean UnionUSD 472 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Production ceased Sept 1, 2014. Total pre-tax charge expected ~$542M. YTD charge $472M includes $343M employee separation costs. Cash payments expected substantially by Q3 2015.
2014-09-30restructuringin_progressAustraliaAsiaUSD 27 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Separation program charges related to factory closures. Includes $4M asset impairment for Canada factory closure.
2014-09-30restructuringin_progressUSD 370,000,000 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2014-06-30plant_closurein_progress2014-04-042014-09-01NetherlandsEuropean UnionUSD 488 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Cessation of cigarette production at Bergen op Zoom factory; social plan agreed with trade unions. Total program charge expected at approximately $560 million pre-tax, including $359 million employee separation costs and $129 million asset impairment; up to $72 million implementation costs to be recorded in cost of sales and marketing, administration and research costs. Employee headcount affected not disclosed.
2014-06-30plant_closurein_progress2014-01-012014-12-31AustraliaAsiaUSD 24 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Decision to cease cigarette production in Australia by end of 2014; $24 million pre-tax severance costs for factory closure recorded in six months ended June 30, 2014 ($1 million in Q2). Employee headcount affected not disclosed.
2014-06-30plant_closurein_progress2014-04-042014-09-01Netherlands (Bergen op Zoom)European Union — cigarette manufacturingUSD 488 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Total program pre-tax charge expected to be approximately $560M; $488M recorded in H1 2014, comprising $359M employee separation costs and $129M asset impairment. Up to $72M of implementation costs to be recorded in cost of sales and marketing/administration/research. Approximately $181M of cash payments expected in 2014. No headcount figure disclosed; social plan agreed with trade unions.
2014-06-30plant_closurein_progress2014-12-31AustraliaAsia — cigarette manufacturingUSD 24 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Separation program charges of $24M in H1 2014 ($1M in Q2) for a factory closure; decision to cease cigarette production in Australia by end of 2014. Announcement date not specified in filing.
2014-06-30acquisition_additioncompletedUnited KingdomE-vapor (reduced-risk products)business_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
June 2014 acquisition of 100% of Nicocigs Limited for $103M net of cash acquired, plus contingent payments up to $77M. No employee count disclosed.
2014-06-30plant_closurein_progress2014-04-042014-09-01NetherlandsEuropean UnionUSD 488 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Discontinuation of cigarette production at Bergen op Zoom factory. Charge includes $359M employee separation costs and $129M asset impairment. Total program expected to cost ~$560M.
2014-06-30plant_closurein_progress2014-12-31AustraliaAsiaUSD 24 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Factory closure in Australia. $24M recorded for six months ended June 30, 2014, related to severance costs.
2014-06-30restructuringin_progressUSD 383,000,000 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2014-03-31plant_closurein_progress2014-01-012014-12-31AustraliaAsiaUSD 23 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Decision to cease cigarette production in Australia by end of 2014 and transition production to South Korea affiliate; $23 million pre-tax charge ($16 million after tax) for severance related to the factory closure.
2014-03-31plant_closureannounced2014-04-042014-10-31NetherlandsEuropean UnionMD&A
f5-10q / GLM-5.3-flash-fp4-HTML
Subsequent event: affiliate Philip Morris Holland B.V. began consultations with employee representatives on a proposal to discontinue cigarette production at the Bergen op Zoom factory, anticipated to be implemented by October 2014 subject to consultation outcomes.
2014-03-31plant_closurein_progress2014-03-312014-12-31AustraliaAsia segment — cigarette manufacturingUSD 23 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Decision made in Q1 2014 to cease Australian cigarette production by end of 2014 and transition output to the South Korean affiliate; charge covers severance for the factory closure. No employee count disclosed.
2014-03-31plant_closureannounced2014-04-042014-10-31NetherlandsEuropean Union segment — cigarette manufacturingother
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Post-quarter announcement: Philip Morris Holland B.V. began consultations with employee representatives on discontinuing cigarette production at the Bergen op Zoom factory; implementation anticipated by October 2014 subject to consultation outcome. Excluded from 2014 EPS guidance; no employee count or charge disclosed.
2014-03-31plant_closureannounced2014-03-312014-12-31AustraliaManufacturingUSD 23 (millions)MD&A
f5-10q / Qwen3.6-27B-Q8_0
Decision to cease cigarette production in Australia by end of 2014 and transition to South Korea affiliate. Pre-tax asset impairment and exit costs of $23 million recorded, related to severance costs for factory closure. Employee count not disclosed.
2014-03-31plant_closureannounced2014-04-042014-10-31NetherlandsManufacturingsubsequent_events
f5-10q / Qwen3.6-27B-Q8_0
Initiation of consultations with employee representatives on proposal to discontinue cigarette production at Bergen op Zoom factory. Implementation anticipated by October 2014 subject to consultation outcome. No charge recorded in Q1 2014.
2014-03-31restructuringin_progressUSD 23,000,000 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2013-12-31restructuringcompleted2013European UnionGlobal and regional functionsUSD 13 (millions)restructuring_footnote
f5-10k / GLM-5.3-flash-HTML
2013 pre-tax separation program charge; filing states charges primarily related to restructuring of global and regional functions based in Switzerland and Australia; no employee count disclosed. Exit-cost cash payments expected to continue substantially into 2014.
2013-12-31restructuringcompleted2013Eastern Europe, Middle East & AfricaGlobal and regional functionsUSD 14 (millions)restructuring_footnote
f5-10k / GLM-5.3-flash-HTML
2013 pre-tax separation program charge; no employee count disclosed. Exit-cost cash payments expected to continue substantially into 2014.
2013-12-31restructuringcompleted2013AsiaGlobal and regional functionsUSD 19 (millions)restructuring_footnote
f5-10k / GLM-5.3-flash-HTML
2013 pre-tax separation program charge; filing links 2013 charges primarily to restructuring of global and regional functions based in Switzerland and Australia; no employee count disclosed. Exit-cost cash payments expected to continue substantially into 2014.
2013-12-31restructuringcompleted2013Latin America & CanadaGlobal and regional functionsUSD 5 (millions)restructuring_footnote
f5-10k / GLM-5.3-flash-HTML
2013 pre-tax separation program charge; no employee count disclosed. Exit-cost cash payments expected to continue substantially into 2014.
2013-12-31restructuringin_progressEgyptEastern Europe, Middle East & Africa — distributionUSD 250 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
New business model in Egypt (contract manufacturing with Eastern Company, new PMI affiliate, new distributor) recorded in Q4 2013; charge reduced reported diluted EPS by about $0.10. Headcount impact not disclosed.
2013-12-31restructuringin_progressAsiaAsia — distributionUSD 8 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Exit costs for termination of a distribution agreement in Asia during 2013; headcount impact not disclosed.
2013-12-31restructuringin_progressSwitzerland and Australia (global and regional functions)European UnionUSD 13 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
2013 separation program charges; segment-level split of the $51 million total. Headcount affected not disclosed.
2013-12-31restructuringin_progressSwitzerland and Australia (global and regional functions)Eastern Europe, Middle East & AfricaUSD 14 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
2013 separation program charges; segment-level split of the $51 million total. Headcount affected not disclosed.
2013-12-31restructuringin_progressSwitzerland and Australia (global and regional functions)AsiaUSD 19 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
2013 separation program charges; segment-level split of the $51 million total. Headcount affected not disclosed.
2013-12-31restructuringin_progressSwitzerland and Australia (global and regional functions)Latin America & CanadaUSD 5 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
2013 separation program charges; segment-level split of the $51 million total. Headcount affected not disclosed.
2013-12-31acquisition_additioncompleted2013-05-012013-09-30MexicoLatin America & CanadaUSD 703 (millions)business_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Purchase of Grupo Carso's remaining 20% interest completed September 30, 2013, giving PMI 100% of its Mexican tobacco business; purchase price shown, no headcount disclosed. Announcement month only (May 2013).
2013-12-31restructuringcompleted2013-01-012013-12-31GlobalGlobal and regional functionsUSD 309 (millions)MD&A
f5-10k / Qwen3.6-27B-Q8_0
Pre-tax asset impairment and exit costs related to termination of distribution agreements in EEMA and Asia, and restructuring of global/regional functions in Switzerland and Australia.
2013-12-31restructuringin_progressUSD 309,000,000 (absolute)restructuring_footnote
f5-10k / no-ai-xblr
2013-09-30restructuringannounced1702013-09-30SwitzerlandGlobal and regional functionsrestructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
PMI announced intention to restructure global and regional functions based in Switzerland; plans expected to be finalized in Q4 2013. MD&A indicates anticipated Q4 2013 charge of approximately $0.03 per diluted share.
2013-09-30restructuringannounced1702013-09-302013-12-31SwitzerlandGlobal and regional functionsrestructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Approximately 170 positions to be eliminated or relocated; plans to be finalized in Q4 2013. MD&A indicates the charge is expected to reduce Q4 2013 diluted EPS by about $0.03; no dollar charge quantified in the footnote.
2013-09-30othercompleted2013-05-312013-09-30MexicoMexican tobacco businessbusiness_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Completed purchase of Grupo Carso's remaining 20% interest in the Mexican tobacco business for $703 million; no headcount change disclosed.
2013-09-30acquisition_additioncompleted2013-09-302013-09-30United Arab Emirates / AlgeriaEquity investment in AITA (49% interest)other
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Acquired 49% equity interest in Arab Investors-TA for approximately $625 million; equity-method investment, no headcount added to consolidated workforce and none disclosed.
2013-09-30restructuringannounced1702013-09-302013-12-31SwitzerlandGlobal and regional functionsMD&A
f5-10q / Qwen3.6-27B-Q8_0
Announced intention to restructure global and regional functions based in Switzerland. Expected to eliminate or relocate approximately 170 positions. Plans to be finalized in Q4 2013. Charge expected to reduce diluted EPS by approx $0.03 in Q4 2013.
2013-09-30restructuringin_progressUSD -8,000,000 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2013-09-30restructuringin_progress170Employee Severance [Member]restructuring_footnote
f5-10q / no-ai-xblr
Expected positions to be eliminated
2013-06-30restructuringcompletedLatin America & CanadaManufacturingUSD 16 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Prior-year (2012) separation program charges for manufacturing footprint optimization; no employee count disclosed. Included as context for exit cost liability roll-forward.
2013-06-30restructuringin_progress2013-12-31AsiaDistributionUSD 8 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
2013 exit costs for termination of distribution agreements; no employee headcount disclosed. Exit cost liability expected to be substantially paid by end of 2013.
2013-06-30restructuringin_progress2013-12-31AsiaUSD 8 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Pre-tax exit costs of $8 million recorded for six months ended June 30, 2013, related to termination of distribution agreements. Employee count not disclosed. Future cash payments expected to be substantially paid by end of 2013.
2013-06-30restructuringin_progressUSD -8,000,000 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2013-03-31restructuringin_progress2013-12-31AsiaDistributionUSD 3 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Pre-tax asset impairment and exit costs of $3 million related to termination of distribution agreements. Future cash payments expected to be approximately $18 million, substantially paid by end of 2013.
2013-03-31restructuringcompletedLatin America & CanadaManufacturingUSD 8 (millions)MD&A
f5-10q / Qwen3.6-27B-Q8_0
Prior year (2012) pre-tax asset impairment and exit costs of $8 million related to severance costs for a factory restructuring. Included for context of comparative period.
2013-03-31restructuringin_progressUSD -3,000,000 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2012-12-31restructuringin_progress2012AsiaAsia segment — factory restructurings (severance)USD 13 (millions)restructuring_footnote
f5-10k / GLM-5.3-flash-HTML
Pre-tax separation-program severance charge recorded during fiscal 2012; no specific announcement date or employee count disclosed. Filer's combined exit-cost liability of about $20 million at year-end 2012 is expected to be substantially paid during 2013.
2012-12-31restructuringin_progress2012Latin America & CanadaLatin America & Canada segment — factory restructurings (severance)USD 29 (millions)restructuring_footnote
f5-10k / GLM-5.3-flash-HTML
Pre-tax separation-program severance charge recorded during fiscal 2012; MD&A attributes this segment's 2012 exit costs mainly to restructuring of manufacturing facilities. No employee count disclosed. Together with the Asia record, components sum to the disclosed $42 million total 2012 separation-program charge.
2012-12-31restructuringin_progressAsiaAsia segment — factory restructuringsUSD 13 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
2012 pre-tax separation program charges in Asia, primarily severance for factory restructurings; no employee-affected count disclosed. Exit cost liabilities of $20 million remained at year-end, expected to be substantially paid by 2013.
2012-12-31restructuringin_progressLatin America & CanadaLatin America & Canada segment — manufacturing facility restructuringUSD 29 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
2012 pre-tax separation program charges, primarily severance related to factory restructurings; no employee-affected count disclosed.
2012-12-31restructuringin_progressMultiple (EU, EEMA, Asia, Latin America & Canada)Research & development — consolidation of R&D activities; factory restructuringsUSD 28 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
2012 pre-tax asset impairment charges (EU $5M, EEMA $5M, Asia $13M, Latin America & Canada $5M) related to R&D consolidation and factory restructurings; no employee-affected counts disclosed. Total 2012 asset impairment and exit costs were $83 million.
2012-12-31restructuringcompletedGlobalManufacturing and R&DUSD 83 (millions)MD&A
f5-10k / Qwen3.6-27B-Q8_0
Pre-tax asset impairment and exit costs of $83 million primarily related to factory restructurings, consolidation of R&D activities, and contract termination charges in Asia.
2012-12-31restructuringin_progressUSD -55,000,000 (absolute)restructuring_footnote
f5-10k / no-ai-xblr
2012-09-30restructuringin_progressAsiaFactory restructuringsUSD 13 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Nine-month 2012 pre-tax separation program charge primarily related to severance costs associated with factory restructurings in Asia.
2012-09-30restructuringin_progressLatin America & CanadaFactory restructuringsUSD 24 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Nine-month 2012 pre-tax separation program charge primarily related to severance costs associated with factory restructurings in Latin America & Canada.
2012-09-30othercompletedAsiaDistribution agreement terminationUSD 5 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Third-quarter 2012 exit costs related to termination of a distribution agreement in Asia.
2012-09-30restructuringin_progressAsiaFactory restructuringsUSD 6 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Third-quarter 2012 pre-tax asset impairment charge related to factory restructurings in Asia.
2012-09-30restructuringin_progressLatin America & CanadaFactory restructuringsUSD 2 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Third-quarter 2012 pre-tax asset impairment charge related to factory restructurings in Latin America & Canada.
2012-09-30restructuringin_progress2013-12-31AsiaManufacturingUSD 13 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Pre-tax separation program charges for nine months ended September 30, 2012, primarily severance for factory restructurings. Related asset impairment charges of $6M also recorded. Exit cost liability balance of $36M at period end; future cash payments expected substantially paid by 2013. Employee headcount not disclosed.
2012-09-30restructuringin_progress2013-12-31Latin America & CanadaManufacturingUSD 24 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Pre-tax separation program charges for nine months ended September 30, 2012, primarily severance for factory restructurings. Related asset impairment charges of $2M also recorded. Exit cost liability balance of $36M at period end; future cash payments expected substantially paid by 2013. Employee headcount not disclosed.
2012-09-30restructuringin_progress2013-12-31Asia; Latin America & CanadaFactory restructuringsUSD 8 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Pre-tax asset impairment charges of $8 million recorded in Q3 2012 related to factory restructurings. Employee count not disclosed.
2012-09-30restructuringin_progress2013-12-31Asia; Latin America & CanadaFactory restructuringsUSD 42 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Pre-tax separation program charges of $42 million recorded for the nine months ended Sept 30, 2012, primarily related to severance costs. Employee count not disclosed. Future cash payments expected to be substantially paid by 2013.
2012-09-30othercompletedAsiaDistributionUSD 5 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Exit costs of $5 million recorded in Q3 2012 related to the termination of a distribution agreement. Employee count not disclosed.
2012-09-30restructuringin_progressUSD -42,000,000 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2012-06-30restructuringin_progressLatin America & CanadaManufacturing footprint optimizationUSD 16 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Pre-tax separation program charges for six months ended June 30, 2012, primarily severance costs tied to ongoing manufacturing footprint optimization; no employee count disclosed.
2012-06-30restructuringin_progressLatin America & CanadaManufacturing footprint optimizationUSD 8 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Pre-tax separation program charges for the three months ended June 30, 2012; no employee count disclosed.
2012-06-30plant_closurecompletedBrazilManufacturingother
f5-10q / GLM-5.3-flash-fp4-HTML
Subsidiaries are defendants in individual employment cases arising from terminations connected with the shutdown of a factory in Brazil; affected-employee count not disclosed.
2012-06-30restructuringin_progressLatin America & CanadaManufacturing (separation program)USD 16 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Six-month 2012 pre-tax separation program charge for severance tied to manufacturing footprint optimization. No employee count disclosed. Exit cost liability was $22M at 2012-06-30; remaining cash payments expected to be substantially paid by 2013.
2012-06-30restructuringin_progress2013-12-31Latin America & CanadaManufacturingUSD 16 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Pre-tax asset impairment and exit costs of $16 million recorded for six months ended June 30, 2012, primarily related to severance costs associated with ongoing optimization of manufacturing footprint. Future cash payments expected to be approximately $22 million, substantially paid by 2013.
2012-06-30restructuringin_progressUSD -16,000,000 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2012-03-31restructuringin_progress2012-12-31Latin America & CanadaManufacturingUSD 8 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Pre-tax separation program charge of $8 million for severance related to a factory restructuring; no employee count disclosed. Future cash payments for exit costs incurred to date expected to be approximately $22 million, substantially paid by end of 2012.
2012-03-31restructuringin_progress2012-12-31Latin America & CanadaManufacturing (factory restructuring)USD 8 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Q1 2012 pre-tax separation program charge for severance related to a factory restructuring; no employee count disclosed. Exit cost liability was $22M at 2012-03-31, expected to be substantially paid by end of 2012.
2012-03-31restructuringin_progress2012-12-31Latin America & CanadaManufacturingUSD 8 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Pre-tax asset impairment and exit costs of $8 million related to severance costs for a factory restructuring. Future cash payments expected to be approximately $22 million, substantially paid by end of 2012.
2011-12-31restructuringcompleted2012-12-31European UnionManufacturing and R&D facilities (factory and R&D restructurings)USD 35 (millions)restructuring_footnote
f5-10k / GLM-5.3-flash-HTML
2011 separation-program severance charges primarily for factory and R&D restructurings. The EU also recorded $10 million of asset impairment charges in 2011, bringing total EU exit costs to $45 million. No employee counts disclosed. Residual group exit-cost liability of approximately $28 million at year-end is expected to be substantially paid by the end of 2012.
2011-12-31restructuringcompleted2012-12-31Eastern Europe, Middle East & AfricaFactory and R&D restructurings (per aggregate program description)USD 6 (millions)restructuring_footnote
f5-10k / GLM-5.3-flash-HTML
2011 separation-program severance charges. EEMA's total 2011 exit costs of $25 million also included $7 million of asset impairment charges and a $12 million third-quarter contract termination charge for a distribution agreement, which is a non-workforce item and therefore excluded from this record.
2011-12-31restructuringcompleted2012-12-31AsiaFactory and R&D restructurings (per aggregate program description)USD 7 (millions)restructuring_footnote
f5-10k / GLM-5.3-flash-HTML
2011 separation-program severance charges; Asia also recorded $8 million of asset impairment charges, bringing total Asia exit costs to $15 million. No employee counts disclosed.
2011-12-31plant_closurecompleted2012-12-31Uruguay and VenezuelaLatin America & Canada — manufacturing facilitiesUSD 24 (millions)MD&A
f5-10k / GLM-5.3-flash-HTML
MD&A attributes LAC's 2011 pre-tax asset impairment and exit costs of $24 million 'primarily' to the closure of manufacturing facilities in Uruguay and Venezuela. Note 5 composition: $15 million separation-program severance plus $9 million asset impairment charges. Captured as one consolidated action (rather than separate LAC severance and impairment records) to avoid double-counting; number of affected employees not disclosed.
2011-12-31restructuringin_progressEuropean UnionEuropean Union segment — factory and R&D restructuringsUSD 35 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
2011 pre-tax separation program charges; primarily severance for factory and R&D restructurings. Employees affected not disclosed.
2011-12-31restructuringin_progressEastern Europe, Middle East & AfricaEEMA segment — separation programsUSD 6 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
2011 pre-tax separation program charges. Employees affected not disclosed.
2011-12-31restructuringin_progressAsiaAsia segment — separation programsUSD 7 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
2011 pre-tax separation program charges. Employees affected not disclosed.
2011-12-31plant_closurein_progressUruguay and VenezuelaLatin America & Canada segment — manufacturing facilitiesUSD 15 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Separation program charges primarily related to closure of manufacturing facilities in Uruguay and Venezuela; a further $9 million of 2011 asset impairment charges in this segment related to the same closures. Employees affected not disclosed.
2011-12-31othercompletedEastern Europe, Middle East & AfricaEEMA segment — distributionUSD 12 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Exit costs recorded in Q3 2011 for termination of a distribution agreement; charge recorded, workforce impact not quantified.
2011-12-31acquisition_additioncompleted2011-06-302011-06-30JordanCigarette manufacturing assets and inventoriesbusiness_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Acquisition completed June 2011 for $42 million; headcount added not disclosed.
2011-12-31acquisition_additioncompleted2011-01-312011-01-31Australia and New ZealandCigar business — trademarksbusiness_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Acquisition completed January 2011 for $20 million, consisting primarily of trademarks; headcount added not disclosed.
2011-12-31restructuringcompleted2011-01-012011-12-31GlobalManufacturing and R&DUSD 63 (millions)restructuring_footnote
f5-10k / Qwen3.6-27B-Q8_0
Pre-tax separation program charges of $63 million primarily related to severance costs for factory and R&D restructurings. Employee count not disclosed.
2011-12-31acquisition_additioncompleted2002010-06-012010-12-31BrazilAgriculture/Supply Chainbusiness_combinations_footnote
f5-10k / Qwen3.6-27B-Q8_0
PMB offered employment to more than 200 employees, mostly agronomy specialists, following agreements with AOB and ULT to source tobacco leaf directly.
2011-09-30restructuringin_progress2012-12-31European UnionFactory and R&D restructuringsUSD 23 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Nine-month pre-tax separation program charge, primarily severance for factory and R&D restructurings; no employee count disclosed
2011-09-30restructuringin_progress2012-12-31Eastern Europe, Middle East & AfricaFactory and R&D restructuringsUSD 6 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Nine-month pre-tax separation program charge; no employee count disclosed
2011-09-30restructuringin_progress2012-12-31AsiaFactory and R&D restructuringsUSD 7 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Nine-month pre-tax separation program charge; no employee count disclosed
2011-09-30restructuringin_progress2012-12-31Latin America & CanadaFactory and R&D restructuringsUSD 9 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Nine-month pre-tax separation program charge, primarily severance; no employee count disclosed
2011-09-30othercompletedEastern Europe, Middle East & AfricaDistributionUSD 12 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Third-quarter 2011 exit cost for termination of a distribution agreement; no employee count disclosed
2011-09-30restructuringin_progress2012-12-31European UnionManufacturing and R&DUSD 23 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Nine-month 2011 separation program charges for factory and R&D restructurings; employee counts not disclosed.
2011-09-30restructuringin_progress2012-12-31Eastern Europe, Middle East & AfricaManufacturing and R&DUSD 6 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Nine-month 2011 separation program charges; employee counts not disclosed.
2011-09-30restructuringin_progress2012-12-31AsiaManufacturing and R&DUSD 7 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Nine-month 2011 separation program charges; employee counts not disclosed.
2011-09-30restructuringin_progress2012-12-31Latin America & CanadaManufacturing and R&DUSD 9 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Nine-month 2011 separation program charges; employee counts not disclosed.
2011-09-30acquisition_additioncompleted2011-06-30JordanCigarette manufacturingUSD 42 (millions)business_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Acquisition of a Jordanian cigarette business (manufacturing assets and inventories) completed June 2011; headcount added not disclosed.
2011-09-30acquisition_additioncompleted2011-01-31Australia and New ZealandCigarsUSD 20 (millions)business_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Acquisition of a cigar business (primarily trademarks) in January 2011; headcount added not disclosed.
2011-09-30restructuringin_progress2012-12-31European UnionFactory and R&DUSD 23 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Pre-tax separation program charges primarily related to severance costs for factory and R&D restructurings.
2011-09-30restructuringin_progress2012-12-31Eastern Europe, Middle East & AfricaFactoryUSD 6 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Pre-tax separation program charges primarily related to severance costs for factory restructurings.
2011-09-30restructuringin_progress2012-12-31AsiaFactoryUSD 7 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Pre-tax separation program charges primarily related to severance costs for factory restructurings.
2011-09-30restructuringin_progress2012-12-31Latin America & CanadaFactory and R&DUSD 9 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Pre-tax separation program charges primarily related to severance costs for factory and R&D restructurings.
2011-09-30restructuringcompletedEastern Europe, Middle East & AfricaDistributionUSD 12 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Exit costs related to the termination of a distribution agreement.
2011-09-30acquisition_additioncompleted2002010-06-01BrazilAgronomybusiness_combinations_footnote
f5-10q / Qwen3.6-27B-Q8_0
PMB offered employment to more than 200 employees, most of them agronomy specialists, following agreements with leaf suppliers.
2011-06-30restructuringin_progressEuropean UnionFactory and R&D restructuringsUSD 12 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Pre-tax separation program charges primarily related to severance costs for factory and R&D restructurings in the European Union; six months ended June 30, 2011.
2011-06-30restructuringin_progressEastern Europe, Middle East & AfricaSeparation programUSD 2 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Six months ended June 30, 2011.
2011-06-30restructuringin_progressAsiaSeparation programUSD 2 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Six months ended June 30, 2011.
2011-06-30restructuringin_progressLatin America & CanadaSeparation programUSD 1 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Six months ended June 30, 2011.
2011-06-30otherin_progressKazakhstanTobacco farming labor practicesMD&A
f5-10q / GLM-5.3-flash-fp4-HTML
Following a July 2010 Human Rights Watch report on migrant tobacco workers, PMI is implementing an Agricultural Labor Practices Code with training and external assessments.
2011-06-30restructuringin_progressEuropean UnionManufacturing and R&DUSD 12 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Pre-tax separation program charge for the six months ended June 30, 2011 ($1 million in Q2); primarily severance for factory and R&D restructurings. No employee count disclosed; exit cost liability expected to be substantially paid by end of 2012.
2011-06-30restructuringin_progressEastern Europe, Middle East & AfricaUSD 2 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Pre-tax separation program charge for the six months ended June 30, 2011; no charge in Q2 2011. No employee count or function disclosed.
2011-06-30restructuringin_progressAsiaUSD 2 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Pre-tax separation program charge for the six months ended June 30, 2011; no charge in Q2 2011. No employee count or function disclosed.
2011-06-30restructuringin_progressLatin America & CanadaUSD 1 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Pre-tax separation program charge for the six months ended June 30, 2011; no charge in Q2 2011. No employee count or function disclosed.
2011-06-30acquisition_additioncompletedJordanbusiness_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Cigarette business acquired June 2011 for $42 million, consisting primarily of manufacturing assets and inventories; no headcount added disclosed.
2011-06-30acquisition_additioncompletedAustralia and New Zealandbusiness_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Cigar business acquired January 2011 for $20 million, consisting primarily of trademarks; no headcount added disclosed.
2011-06-30restructuringin_progress2012-12-31European UnionFactory and R&DUSD 12 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Pre-tax charges primarily related to severance costs for factory and R&D restructurings. Future cash payments expected to be substantially paid by end of 2012.
2011-06-30restructuringin_progress2012-12-31Eastern Europe, Middle East & AfricaSeparation programsUSD 2 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Part of consolidated separation program charges.
2011-06-30restructuringin_progress2012-12-31AsiaSeparation programsUSD 2 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Part of consolidated separation program charges.
2011-06-30restructuringin_progress2012-12-31Latin America & CanadaSeparation programsUSD 1 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Part of consolidated separation program charges.
2011-06-30acquisition_additioncompleted2010-06-01BrazilAgriculture/Supply Chainbusiness_combinations_footnote
f5-10q / Qwen3.6-27B-Q8_0
PMI affiliate offered employment to more than 200 employees, most of them agronomy specialists, following agreements with leaf suppliers.
2011-03-31restructuringin_progress2012-12-31European UnionFactory and R&D restructuringsUSD 11 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Q1 2011 pre-tax separation program charge primarily for severance costs for factory and R&D restructurings in the European Union.
2011-03-31restructuringin_progress2012-12-31Eastern Europe, Middle East & AfricaSeparation programUSD 2 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
2011-03-31restructuringin_progress2012-12-31AsiaSeparation programUSD 2 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
2011-03-31restructuringin_progress2012-12-31Latin America & CanadaSeparation programUSD 1 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
2011-03-31restructuringin_progress2012-12-31European UnionManufacturing and R&DUSD 16 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Separation programs in EU ($11M), EEMA ($2M), Asia ($2M), Latin America & Canada ($1M); charges primarily severance for factory and R&D restructurings in the EU. No employee counts disclosed. Exit cost liability $62M at 2011-03-31, expected substantially paid by end of 2012.
2011-03-31restructuringin_progress2012-12-31European UnionFactory and R&DUSD 11 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Pre-tax charges primarily related to severance costs for factory and R&D restructurings. Future cash payments expected to be substantially paid by end of 2012.
2011-03-31restructuringin_progress2012-12-31Eastern Europe, Middle East & AfricaUSD 2 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Part of total separation programs.
2011-03-31restructuringin_progress2012-12-31AsiaUSD 2 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Part of total separation programs.
2011-03-31restructuringin_progress2012-12-31Latin America & CanadaUSD 1 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Part of total separation programs.
2011-03-31acquisition_additioncompleted2002010-06-01BrazilAgronomy specialistsbusiness_combinations_footnote
f5-10q / Qwen3.6-27B-Q8_0
PMB offered employment to more than 200 employees, most of them agronomy specialists, following agreements with leaf suppliers.
2010-12-31restructuringin_progress2012-12-31European Union (factory restructuring in Greece, the Netherlands and Portugal)European Union segment — manufacturingUSD 27 (millions)restructuring_footnote
f5-10k / GLM-5.3-flash-HTML
Filer labels these 'separation programs'; 2010 pre-tax charges of $27 million were primarily severance costs in the European Union, and MD&A ties them to factory restructuring in Greece, the Netherlands and Portugal (Q4 2010 per Note 22 quarterly data). No employee count disclosed. Exit-cost liability was $48 million at year-end 2010, with remaining cash payments expected to be substantially paid by end of 2012 (basis for expected_completion_date). Note 13 adds that salaried employees left under separation programs during 2010, with incremental postemployment costs included in net postemployment 'other expense'.
2010-12-31othercompletedPhilippinesAsia segmentUSD 20 (millions)restructuring_footnote
f5-10k / GLM-5.3-flash-HTML
Contract termination charge for early termination of a transition services agreement between FTC and PMFTC; no employee headcount impact disclosed. Note 5 dates the charge to Q4 2010, while the Note 22 quarterly data table shows $20 million of asset impairment and exit costs in Q3 2010.
2010-12-31acquisition_additioncompleted2002010-06Brazil (Southern Brazil)Leaf tobacco sourcing / agronomyUSD 83 (millions)business_combinations_footnote
f5-10k / GLM-5.3-flash-HTML
Affiliate PMB offered employment to more than 200 employees (count recorded as 200 reflects the 'more than 200' floor), most of them agronomy specialists, after leaf suppliers AOB and ULT assigned approximately 17,000 farmer contracts; accounted for as a business combination. The $83 million is the purchase price for net assets and contractual relationships, not a severance charge.
2010-12-31restructuringin_progressEuropean UnionEuropean Union segment — factory restructuring (Greece, Netherlands, Portugal) and administrative streamliningUSD 27 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
FY2010 pre-tax separation program charges of $27 million, primarily severance costs in the European Union; related factory restructuring charges in Greece, the Netherlands and Portugal per MD&A. Employee counts not disclosed. Exit cost liability balance was $48 million at 2010-12-31, substantially payable by end of 2012.
2010-12-31restructuringcompleted2010-10-012010-12-31PhilippinesAsia segment — early termination of transition services agreement with Fortune Tobacco CorporationUSD 20 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Exit cost of $20 million recorded in Q4 2010 for early termination of a transition services agreement between FTC and PMFTC. Employee counts not disclosed.
2010-12-31acquisition_additioncompleted2002010-06-012010-12-31BrazilTobacco leaf procurement / supply chainUSD 83 (millions)business_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
PMB offered employment to more than 200 employees (mostly agronomy specialists) and acquired related assets; purchase price for net assets and contractual relationships was $83 million. Announcement month stated as June 2010; exact day not disclosed.
2010-12-31acquisition_additioncompleted2010-02-252010-02-25PhilippinesAsia segment — PMFTC Inc. business combination with Fortune Tobacco Corporationbusiness_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Non-cash business combination; contributed FTC net assets fair-valued at $1.17 billion. Headcount added not disclosed. Shipment volume contribution of 57.4 billion units in 2010.
2010-12-31otherannounced2011-01-012011-01-01VietnamAsia segment — new business structure with VinatabaItem_1_Business
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Effective 2011-01-01, licensing of Marlboro and establishment of a PMI-controlled branch in Vietnam. Headcount implications not quantified.
2010-12-31restructuringcompleted2010-01-012012-12-31Greece, Netherlands, PortugalManufacturingUSD 47 (millions)restructuring_footnote
f5-10k / Qwen3.6-27B-Q8_0
Pre-tax asset impairment and exit costs of $47 million related to factory restructuring charges in Greece, the Netherlands and Portugal, and a contract termination charge in the Philippines. Future cash payments for exit costs incurred to date are expected to be approximately $48 million, substantially paid by end of 2012.
2010-12-31acquisition_additioncompleted2002010-06-012010-06-30BrazilAgriculture/Supply ChainUSD 83 (millions)business_combinations_footnote
f5-10k / Qwen3.6-27B-Q8_0
PMB offered employment to more than 200 employees, most of them agronomy specialists, following agreements with leaf suppliers AOB and ULT.
2010-09-30restructuringin_progress2012-12-31Greece and PortugalEuropean UnionUSD 20 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Factory restructuring charges primarily severance; exit cost liability of $51 million at 2010-09-30, with remaining cash payments of approximately $51 million expected to be paid by 2012. Cash paid for exit costs was $48 million in the nine months ended 2010-09-30.
2010-09-30acquisition_additionin_progress2002010-06-01Southern BrazilLatin America & Canada — leaf procurementUSD 83 (millions)business_combinations_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
PMB will directly source tobacco leaf from approximately 17,000 farmers and will offer employment to more than 200 employees, most of them agronomy specialists; purchase price approximately $83 million for net assets and contractual relationships, accounted for as a business combination.
2010-09-30restructuringin_progress2012Greece and PortugalEuropean UnionUSD 20 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Separation program charges primarily severance-related for factory restructuring; $48M cash paid in nine months ended 2010-09-30; remaining exit-cost liability of $51M expected to be paid by 2012. No employee count disclosed.
2010-09-30acquisition_additionin_progress2002010-062010-12-31BrazilLeaf procurementbusiness_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Filer states PMB will offer employment to more than 200 employees, mostly agronomy specialists; count captured as stated lower bound. Purchase price approx $83M, $41M paid as of 2010-09-30; allocation to be finalized in Q4 2010.
2010-09-30acquisition_additioncompleted2010-02-252010-02-25PhilippinesAsiabusiness_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Non-cash combination of PMPMI and Fortune Tobacco into PMFTC; filing discloses no headcount figures for the transaction.
2010-09-30restructuringin_progress2012-12-31European UnionAdministrative functions and operationsUSD 20 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Pre-tax charges primarily related to severance costs for streamlining administrative functions and operations. Future cash payments expected to be approx. $51 million by 2012.
2010-09-30acquisition_additioncompleted2002010-06-01BrazilAgronomy specialistsUSD 83 (millions)business_combinations_footnote
f5-10q / Qwen3.6-27B-Q8_0
Acquisition of leaf procurement business assets and contracts. PMB will offer employment to more than 200 employees, most of them agronomy specialists.
2010-06-30acquisition_additionannounced2002010-06-012010-12-31Brazil (Southern Brazil)Leaf tobacco procurement / Latin America & CanadaUSD 90 (millions)MD&A
f5-10q / GLM-5.3-flash-fp4-HTML
Philip Morris Brasil will directly source tobacco leaf from ~17,000 farmers and offer employment to more than 200 employees, mostly agronomy specialists, acquiring related assets; estimated purchase price ~$90 million, subject to CADE approval and final contract count.
2010-06-30voluntary_separationannounced12010-06-152010-08-31Switzerland (Lausanne)Philip Morris International Management S.A.CHF 1,054,560 (units)other
f5-10q / GLM-5.3-flash-fp4-HTML
Individual early retirement agreement; employment ends August 31, 2010 with physical exit July 1, 2010. Gross payment of CHF 1,054,560 in two installments tied to non-compete compliance, plus pro-rated 2010 incentive compensation.
2010-06-30acquisition_additioncompleted2010-02-252010-02-25PhilippinesAsia segmentbusiness_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
PMFTC Inc. formed Feb 25, 2010 combining PMPMI and Fortune Tobacco; workforce added through consolidation but no employee count disclosed. Volume impact of 23.3 billion units cited in MD&A.
2010-06-30acquisition_additionannounced2002010-062010-12-31BrazilLeaf procurement / supply chainUSD 90 (millions)business_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
PMB to employ more than 200 people (mostly agronomy specialists) via assignment of ~17,000 farmer contracts; $90M is estimated purchase price for net assets and contractual relationships, not a severance charge. Subject to CADE approval; to be accounted for as a business combination.
2010-06-30restructuringin_progress2012-12-31European UnionEuropean Union segmentUSD 43 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Exit cost liability rolled from $84M (Jan 1, 2010) to $43M (Jun 30, 2010) after $33M cash spent and $(8)M currency/other; no new charges in 2010. Filing does not state number of employees affected; remaining future cash payments expected substantially paid by 2012.
2010-06-30acquisition_additioncompleted2002010-06-302010-12-31BrazilSupply Chain / AgronomyUSD 90 (millions)business_combinations_footnote
f5-10q / Qwen3.6-27B-Q8_0
PMB to offer employment to more than 200 employees, most agronomy specialists, as part of direct sourcing initiative.
2010-06-30voluntary_separationcompleted12010-07-102010-08-31SwitzerlandSenior ManagementUSD 1 (millions)subsequent_events
f5-10q / Qwen3.6-27B-Q8_0
Retirement of Jean-Claude Kunz, former President EEMA Region & PMI Duty Free. Lump sum payment of approx $998k.
2010-03-31acquisition_additioncompleted2010-02-25PhilippinesAsia segmentbusiness_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
PMFTC business combination added 6.1 billion units of incremental volume; no employee headcount disclosed.
2010-03-31restructuringin_progress2012-12-31Not specifiedEuropean Union segment (prior period charge)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Exit cost liability of $51M at quarter-end; $29M cash spent in Q1 2010; no employee counts disclosed. No new charges in Q1 2010.
2010-03-31restructuringin_progress2012-12-31GlobalVariousUSD 29 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Cash payments related to exit costs were $29 million for the three months ended March 31, 2010. Future cash payments for exit costs incurred to date are expected to be approximately $51 million, substantially paid by 2012. No specific employee count is disclosed.
2009-12-31restructuringcompletedEuropean UnionEuropean Union segment; streamlining of administrative functions and operationsUSD 29 (millions)restructuring_footnote
f5-10k / GLM-5.3-flash-HTML
2009 pre-tax separation program charges of $29 million ($19 million after tax), primarily severance, recorded in the EU segment; affected headcount not disclosed. Residual exit-cost liability of $84 million at December 31, 2009 (covering 2007-2009 programs) expected to be substantially paid by 2012; cash payments for exit costs were $56 million in 2009.
2009-12-31restructuringin_progress2012-12-31European UnionEuropean Union segment — separation programsUSD 29 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
2009 pre-tax separation program charges, primarily severance; no headcount affected disclosed. Cash payments on exit costs were $56 million in 2009 and remaining liability was $84 million at year-end, substantially payable by 2012.
2009-12-31acquisition_additioncompleted2009-09-302009-09-30South AfricaOther tobacco productsUSD 256 (millions)business_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Acquired for ZAR 1.93 billion (approximately $256 million) including acquired cash; purchase price allocated primarily to goodwill ($163 million). No acquired headcount disclosed.
2009-12-31acquisition_additioncompleted2009-02-282009-02-28Norway, SwedenOther tobacco products — fine-cut tobaccobusiness_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Purchase of the Petterøes tobacco business, comprising fine-cut trademarks sold primarily in Norway and Sweden. Consideration and acquired headcount not disclosed; effect stated as not material.
2009-12-31acquisition_additionannounced2009-07-312010-06-30ColombiaLatin America & Canada segmentUSD 452 (millions)business_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Agreement to purchase 100% of Protabaco for $452 million; subject to competition authority approval, expected to close in the first half of 2010 and projected to be marginally accretive to EPS. No headcount disclosed.
2009-12-31otherannounced2010-02-25PhilippinesAsia segmentsubsequent_events
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Post-year-end agreement to combine PMPMI and Fortune Tobacco into PMFTC Inc. with equal economic interests; PMI to manage operations and hold a majority of the board. FTC holds a put right at $1.17 billion exercisable 2015-2018, recorded as redeemable noncontrolling interest. No headcount disclosed.
2009-12-31othercompleted2009-02-282009-04-01Worldwide (excluding Scandinavia and the United States)Smoke-free tobacco productsItem_1_Business
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Exclusive joint venture with Swedish Match AB to commercialize Swedish-style snus and other smoke-free products; operations began April 1, 2009. Effect not material to 2009 results; no headcount disclosed.
2009-12-31restructuringin_progress2012-12-31WorldwideVarious administrative functions and operationsUSD 29 (millions)MD&A
f5-10k / Qwen3.6-27B-Q8_0
Pre-tax charges of $29 million recorded in 2009 primarily related to separation programs. Future cash payments for exit costs incurred to date expected to be approximately $84 million, substantially paid by 2012.
2009-09-30restructuringin_progressEuropean UnionSeparation programs (administrative functions and operations streamlining)USD 3 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Pre-tax separation program charge for the nine months ended September 30, 2009, primarily severance costs; no employee count disclosed. Cash payments for exit costs were $49 million YTD; remaining exit-cost liability of $67 million at quarter-end, expected to be substantially paid by 2011.
2009-09-30restructuringin_progress2011-12-31European UnionEuropean Union segmentUSD 3 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Nine months 2009 separation program charges of $3 million, primarily severance; no employee count disclosed. Exit cost liability was $67 million at 2009-09-30, with future payments expected to be substantially paid by 2011.
2009-09-30acquisition_additioncompletedSouth Africabusiness_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Acquired Swedish Match South Africa (Proprietary) Limited in September 2009 for ZAR 1.98 billion (~$262 million); no headcount added disclosed.
2009-09-30acquisition_additioncompletedNorway, Swedenbusiness_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Purchased the Petterøes tobacco business in February 2009, primarily definite-lived trademarks; no headcount added disclosed.
2009-09-30acquisition_additionannounced2009-07-31Colombiabusiness_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Agreement announced July 2009 to purchase Protabaco Ltda. for $452 million, subject to competition authority approval; filing states closing expected within six months of announcement. No headcount disclosed.
2009-09-30restructuringin_progress2011-12-31GlobalVarious administrative functions and operationsUSD 3 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Pre-tax charges of $3 million recorded for nine months ended Sept 30, 2009, primarily related to severance costs. Future cash payments expected to be approx $67 million, substantially paid by 2011.
2009-09-30acquisition_additioncompleted2009-09-30South AfricaTobaccoUSD 262 (millions)business_combinations_footnote
f5-10q / Qwen3.6-27B-Q8_0
Acquired Swedish Match South Africa (Proprietary) Limited for approx $262 million. Headcount not disclosed.
2009-09-30acquisition_additioncompleted2009-02-28Norway, SwedenTobaccobusiness_combinations_footnote
f5-10q / Qwen3.6-27B-Q8_0
Purchased Petterøes tobacco business. Assets consisted primarily of trademarks. Headcount not disclosed.
2009-09-30acquisition_additionannounced2009-07-312010-01-31ColombiaTobaccoUSD 452 (millions)subsequent_events
f5-10q / Qwen3.6-27B-Q8_0
Agreement to purchase 100% of Protabaco Ltda. for $452 million. Expected to close within six months. Headcount not disclosed.
2009-06-30restructuringin_progressEuropean UnionEuropean Union segment; administrative functions and operations streamliningUSD 2 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Pre-tax separation program charge primarily severance costs; no employee count disclosed. Exit cost liability of $76 million at June 30, 2009, with future payments substantially paid by 2011.
2009-06-30restructuringin_progress2011-12-31European UnionEuropean Union segment — administrative functions and operationsUSD 2 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Pre-tax separation program charge of $2M in six months ended 2009-06-30, primarily severance; no employee count disclosed. Exit cost liability was $76M at 2009-06-30; future cash payments expected to be substantially paid by 2011.
2009-06-30restructuringin_progress2011-12-31GlobalAdministrative functions and operationsUSD 2 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Pre-tax charges of $2 million recorded for six months ended June 30, 2009, primarily related to severance costs. Future cash payments expected to be approximately $76 million, substantially paid by 2011.
2009-06-30acquisition_additioncompleted2008-07-312008-10-31CanadaLatin America & Canadabusiness_combinations_footnote
f5-10q / Qwen3.6-27B-Q8_0
Acquisition of Rothmans Inc. completed in October 2008. Rothmans became a wholly-owned subsidiary. Headcount not explicitly disclosed.
2009-06-30acquisition_additioncompleted2009-02-012009-02-28Norway and SwedenEuropean Unionbusiness_combinations_footnote
f5-10q / Qwen3.6-27B-Q8_0
Purchase of Petterøes tobacco business in February 2009. Headcount not explicitly disclosed.
2009-06-30acquisition_additionannounced2009-07-012010-01-01ColombiaLatin America & CanadaUSD 452 (millions)subsequent_events
f5-10q / Qwen3.6-27B-Q8_0
Agreement to purchase 100% of shares of Productora Tabacalera de Colombia, Protabaco Ltda. for $452 million. Expected to close within six months.
2009-06-30acquisition_additionannounced2009-07-012009-12-31South AfricaEastern Europe, Middle East and AfricaUSD 222 (millions)subsequent_events
f5-10q / Qwen3.6-27B-Q8_0
Agreement to purchase Swedish Match South Africa (Proprietary) Limited for approximately $222 million. Expected to be completed by end of year.
2009-03-31restructuringin_progress2011-12-31European UnionSeparation programs (administrative functions streamlining)USD 1 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Q1 2009 pre-tax separation program charge primarily severance; exit cost liability moved from $115M at Jan 1, 2009 to $86M at Mar 31, 2009; remaining future payments of approximately $86 million expected to be substantially paid by 2011. No employee count disclosed.
2009-03-31restructuringin_progress2011-12-31European UnionAdministrative functions and operationsUSD 1 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Q1 2009 separation program charge of $1M, primarily severance; exit cost liability was $86M at 2009-03-31 with future cash payments substantially paid by 2011. Number of employees affected not disclosed.
2009-03-31acquisition_additioncompletedNorway; SwedenOther tobacco productsbusiness_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Petterøes tobacco business purchased in February 2009; assets were primarily amortizable intangibles. Headcount added not disclosed; effect described as not material.
2009-03-31restructuringin_progress2011-12-31GlobalAdministrative functions and operationsUSD 1 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Pre-tax charges of $1 million recorded in Q1 2009 primarily related to severance costs. Future cash payments for exit costs incurred to date expected to be approx. $86 million, substantially paid by 2011.
2008-12-31restructuringin_progress3,6002005GlobalAdministrative functions and manufacturing operationsUSD 69 (millions)Item_1_Business
f5-10k / GLM-5.3-flash-HTML
Cumulative position eliminations since program inception in 2005 through December 31, 2008; figure stated as approximately 3,600. Program includes announced closure or partial closure of nine production facilities (largest: Munich, Germany factory, announced 2006). 2008 pre-tax separation-program charges of $69 million (EU $66 million; Latin America & Canada $3 million) were primarily severance; total 2008 asset impairment and exit costs of $84 million additionally included $15 million of PM USA contract termination charges (see separate record). Cash payments for exit costs were $99 million in 2008; exit-cost liability of $115 million remained at December 31, 2008 with future payments of approximately $115 million expected. Cumulative estimated annual cost savings of approximately $295 million through 2008, of which $110 million were incremental in 2008.
2008-12-31restructuringcompleted2008United States to EuropeManufacturing (termination of PM USA contract manufacturing arrangement)USD 15 (millions)restructuring_footnote
f5-10k / GLM-5.3-flash-HTML
Contract manufacturing arrangement with PM USA terminated in 2008; production of approximately 57 billion cigarettes annually (2007 volume) shifted to PMI facilities in Europe, completed in Q4 2008. Exit costs of $15 million recorded in Q1 2008 (Note 4 contract termination charges: Asia $14 million; Eastern Europe, Middle East and Africa $1 million). Pre-tax savings of $71 million generated in 2008; total pre-tax annual savings of approximately $179 million expected by 2009. Employee headcount impact not disclosed.
2008-12-31acquisition_additioncompleted2008-07-312008-10CanadaLatin America & CanadaUSD 2 (billions)business_combinations_footnote
f5-10k / GLM-5.3-flash-HTML
Tender offer for all outstanding Rothmans Inc. common shares at CAD $30 per share (CAD $2.0 billion, approximately USD $1.9 billion) announced July 31, 2008 and completed in October 2008; Rothmans became a consolidated subsidiary. Number of employees added through the acquisition not disclosed.
2008-12-31restructuringin_progress3,6002005-01-01Multiple (global)Administrative functions and production facilitiesUSD 84 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Cumulative through 2008-12-31 for a multi-year streamlining program announced beginning 2005; includes closure or partial closure of nine production facilities (largest: Munich, Germany, announced 2006). Charge shown is the 2008 pre-tax charge only; approximately 3,600 positions eliminated cumulatively. Future cash payments for exit costs incurred to date expected to be approximately $115 million.
2008-12-31restructuringcompleted2008-01-012008-12-31United States / EuropeManufacturing (Manufacturing Optimization Program)USD 15 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Termination of contract manufacturing arrangement with PM USA; approximately 57 billion cigarettes of annual production shifted to European facilities during Q4 2008. Exit costs recorded in Q1 2008; program generated pre-tax savings of $71 million in 2008. No employee count disclosed.
2008-12-31acquisition_additioncompleted2008-07-312008-10-31CanadaLatin America & Canada segmentbusiness_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Tender offer for all outstanding shares of Rothmans Inc. at CAD $30 per share (approximately $1.9 billion); completed October 2008. Rothmans became a consolidated subsidiary; no headcount added disclosed.
2008-12-31acquisition_additioncompleted2008-06-012008-06-30GlobalOther tobacco products (trademark purchase)USD 407 (millions)business_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Purchase of fine cut trademark Interval and other OTP trademarks from Imperial Tobacco Group PLC for $407 million; treated as an asset purchase rather than a business combination, so no headcount addition is disclosed.
2008-12-31restructuringcompleted3,6002005-01-012008-12-31GlobalAdministrative functions and operationsUSD 84 (millions)Item_1_Business
f5-10k / Qwen3.6-27B-Q8_0
Cumulative elimination of approximately 3,600 positions through Dec 31, 2008, resulting from plans announced since 2005. Includes closure of nine production facilities. Pre-tax charge of $84 million recorded in 2008.
2008-09-30restructuringin_progressEuropean UnionSeparation programs (administrative functions and operations streamlining)USD 66 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Pre-tax separation program charges for the nine months ended September 30, 2008; primarily severance costs.
2008-09-30restructuringin_progressLatin America & CanadaSeparation programs (administrative functions and operations streamlining)USD 3 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Pre-tax separation program charges for the nine months ended September 30, 2008.
2008-09-30restructuringin_progressEastern Europe, Middle East and AfricaContract termination chargesUSD 1 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Contract termination charge for the nine months ended September 30, 2008.
2008-09-30restructuringin_progressAsiaContract termination chargesUSD 14 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Contract termination charge for the nine months ended September 30, 2008.
2008-09-30restructuringin_progress3,600Multiple (nine production facilities; largest in Munich, Germany)Administrative functions and manufacturing operations streamliningUSD 84 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Streamlining since 2005 expected to eliminate approximately 3,600 positions; about 3,500 eliminated as of September 30, 2008. Nine-month 2008 pre-tax charges of $84 million; additional ~$4 million expected in remainder of 2008; future cash payments ~$132 million.
2008-09-30plant_closurein_progress2006-01-01Munich, GermanyManufacturingMD&A
f5-10q / GLM-5.3-flash-fp4-HTML
Largest of nine announced production facility closures or partial closures through September 30, 2008; announcement year 2006.
2008-09-30otherin_progress2008-12-31United States / EuropeManufacturing Optimization Program — termination of contract manufacturing arrangement with Philip Morris USAUSD 15 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
PM USA contract-manufactured production (~57 billion cigarettes annually in 2007) shifting to PMI European facilities in Q4 2008; exit costs of $15 million recorded in Q1 2008; ~$50 million capital expenditures expected, $36 million incurred through September 30, 2008; estimated pre-tax annual savings ~$179 million by 2009.
2008-09-30restructuringin_progress3,600GlobalAdministrative functions and operationsUSD 84 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Multi-year streamlining program announced since 2005 covering closure or partial closure of nine production facilities; no specific announcement date disclosed. Approximately 3,500 of the 3,600 targeted positions had been eliminated as of 2008-09-30. Charge shown is pre-tax for the nine months ended 2008-09-30 and includes Manufacturing Optimization Program exit costs. About $4M of additional pre-tax charges expected in the remainder of 2008; future cash payments for exit costs incurred to date expected at approximately $132M. Also referenced in MD&A; sourced once from the footnote.
2008-09-30restructuringin_progress2008-12-31United StatesManufacturingUSD 15 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Manufacturing Optimization Program: contract manufacturing with Philip Morris USA terminated effective no later than 2008-12-31, with roughly 57 billion cigarettes of annual production shifting to PMI facilities in Europe during Q4 2008. No employee count disclosed. $15M exit cost recorded in Q1 2008, included within the $84M nine-month pre-tax charge total; approximately $50M of capital expenditure planned and expected pre-tax annual savings of about $179M by 2009.
2008-09-30acquisition_additioncompleted2008-07-31CanadaLatin America & Canadabusiness_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Tender offer for Rothmans Inc. acquired approximately 93.8% of outstanding shares for about $1.8B as of 2008-09-30; remaining shares purchased by compulsory acquisition in October 2008 (no exact date given). Headcount added through the acquisition was not disclosed.
2008-09-30restructuringin_progress3,6002005-01-012008-12-31GlobalAdministrative functions and operationsUSD 84 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Program announced since 2005 to streamline administrative functions and operations, including closure of nine production facilities. Approximately 3,500 positions eliminated as of Sept 30, 2008. Pre-tax charges of $84M recorded for nine months ended Sept 30, 2008.
2008-09-30restructuringin_progress2008-01-012008-12-31GlobalManufacturingUSD 15 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Manufacturing Optimization Program: Termination of contract manufacturing arrangement with PM USA. Production shifting to PMI facilities in Europe. Exit costs of $15M recorded in Q1 2008.
2008-06-30restructuringin_progress3,600Multiple regionsAdministrative functions and operationsUSD 71 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Streamlining program since 2005; closure or partial closure of 9 production facilities through June 30, 2008, largest being Munich, Germany factory announced in 2006. Approximately 3,250 of the ~3,600 positions eliminated as of June 30, 2008. Six-month 2008 pre-tax charges of $71M split: EU separation programs $56M, EEMA contract termination $1M, Asia contract termination $14M. Additional ~$13M of pre-tax charges expected during remainder of 2008; future cash payments for exit costs incurred to date ~$189M; cumulative estimated annual pre-tax cost savings ~$320M expected by end of 2008.
2008-06-30restructuringin_progress2008-12-31European UnionSeparation programsUSD 56 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
EU separation program charges for the six months ended June 30, 2008; primarily severance costs. Three-month charge was $48 million.
2008-06-30restructuringin_progressAsiaContract terminationUSD 14 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Contract termination charges recorded in the six months ended June 30, 2008.
2008-06-30restructuringin_progressEastern Europe, Middle East and AfricaContract terminationUSD 1 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Contract termination charges recorded in the six months ended June 30, 2008.
2008-06-30otherin_progress2008-12-31United States / EuropeManufacturing Optimization ProgramUSD 15 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Termination of contract manufacturing arrangement with Philip Morris USA effective no later than December 31, 2008; ~57 billion cigarettes of annual contract-manufactured volume (2007) to shift to PMI facilities in Europe by Q4 2008. $15M exit cost recorded in Q1 2008; program entails ~$50M capital expenditures, of which $32M incurred through June 30, 2008. Expected to generate total estimated pre-tax annual cost savings of ~$179 million by 2009.
2008-06-30restructuringin_progress3,600Global (multiple segments)Administrative functions and production facilitiesUSD 71 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Streamlining program announced since 2005 covering closure or partial closure of 9 production facilities; pre-tax charge for six months ended 2008-06-30. Approximately 3,250 of the 3,600 targeted positions eliminated as of 2008-06-30. Additional pre-tax charges of about $13 million expected for the remainder of 2008; future cash payments for exit costs incurred to date expected to be about $189 million. Announcement date not specified (program initiated in 2005).
2008-06-30restructuringin_progress2008-12-31United States / EuropeManufacturing (Manufacturing Optimization Program)USD 15 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Termination of contract manufacturing arrangement with Philip Morris USA effective no later than 2008-12-31; approximately 57 billion cigarettes annually of production to shift to PMI facilities in Europe by Q4 2008. Exit costs of $15 million recorded in Q1 2008. Program entails capital expenditures of about $50 million ($32 million incurred through 2008-06-30) and is expected to save about $179 million in annual pre-tax costs by 2009. No employee count disclosed.
2008-06-30restructuringin_progressEuropean UnionAdministrative functions and operationsUSD 56 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Part of streamlining plans announced since 2005. Total program expected to eliminate ~3,600 positions; ~3,250 eliminated as of June 30, 2008. Specific headcount for this geography not disclosed.
2008-06-30restructuringin_progressEastern Europe, Middle East and AfricaAdministrative functions and operationsUSD 1 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Contract termination charges. Specific headcount not disclosed.
2008-06-30restructuringin_progressAsiaAdministrative functions and operationsUSD 14 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Contract termination charges. Specific headcount not disclosed.
2008-06-30restructuringin_progressGlobalManufacturingUSD 15 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Manufacturing Optimization Program: Termination of contract manufacturing arrangement with PM USA. Shift production to Europe by Q4 2008. Specific headcount not disclosed.
2008-03-31restructuringin_progress3,5002005-01-012008-12-31Global (multiple regions)Administrative functions and operationsUSD 23 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Streamlining program announced since 2005; approximately 2,750 of the 3,500 positions eliminated as of March 31, 2008. Q1 2008 pre-tax charge of $23 million primarily severance; approximately $44 million additional charges expected in remainder of 2008; future cash payments for exit costs incurred to date approximately $174 million; cumulative annual cost savings of approximately $335 million expected by end of 2008.
2008-03-31plant_closurein_progress2006-01-01Munich, Germany and other locationsManufacturingrestructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Closure or partial closure of 9 production facilities announced through March 31, 2008; largest is the Munich, Germany factory announced in 2006. Charges included in the streamlining program totals.
2008-03-31restructuringin_progress2008-01-012008-12-31United States / EuropeManufacturingUSD 15 (millions)restructuring_footnote
f5-10q / GLM-5.3-flash-fp4-HTML
Termination of contract manufacturing arrangement with Philip Morris USA; production of approximately 57 billion cigarettes annually to shift to PMI facilities in Europe by Q4 2008. Q1 2008 exit costs of $15 million (contract termination charges in EEMA $1 million and Asia $14 million); capital expenditures of approximately $50 million expected, of which $17 million incurred through March 31, 2008; estimated pre-tax annual cost savings of approximately $179 million by 2009.
2008-03-31restructuringin_progress3,5002008-12-31Global (European Union, EEMEA, Asia, Latin America)Administrative functions and production facilitiesUSD 8 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Multi-year streamlining program announced since 2005 targeting elimination of ~3,500 positions; ~2,750 eliminated as of 2008-03-31. Q1 2008 separation-program charge was $8M pre-tax; additional ~$44M pre-tax charges expected remainder of 2008. Program includes closure/partial closure of 9 production facilities. Exit cost liability was $174M at quarter-end; future cash payments for exit costs to date expected ~$174M. Cumulative annual cost savings of ~$335M expected by end of 2008.
2008-03-31restructuringin_progress2008-12-31United States to EuropeManufacturing — contract manufacturing termination with PM USAUSD 15 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML
PMI terminated its contract manufacturing arrangement with PM USA in 2008, shifting ~57 billion cigarettes annually of production to PMI facilities in Europe by Q4 2008. $15M exit costs recorded in Q1 2008 (contract termination charges: $14M Asia, $1M EEMEA). Program entails ~$50M capex ($17M incurred through 2008-03-31). Expected to save ~$179M pre-tax annually by 2009. No employee headcount impact disclosed.
2008-03-31restructuringin_progress2,750GlobalAdministrative functions and operationsUSD 23 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Cumulative positions eliminated as of March 31, 2008, from streamlining plans announced since 2005. Total expected elimination is approximately 3,500 positions.
2008-03-31restructuringin_progress2008-12-31EuropeManufacturingUSD 15 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0
Manufacturing Optimization Program: Termination of contract manufacturing arrangement with PM USA. Production shifting to PMI facilities in Europe by Q4 2008. Employee count not explicitly disclosed for this specific component.